BioMed Research International

BioMed Research International / 2014 / Article
Special Issue

Prooxidant Mechanisms in Toxicology

View this Special Issue

Review Article | Open Access

Volume 2014 |Article ID 761264 |

Anu Rahal, Amit Kumar, Vivek Singh, Brijesh Yadav, Ruchi Tiwari, Sandip Chakraborty, Kuldeep Dhama, "Oxidative Stress, Prooxidants, and Antioxidants: The Interplay", BioMed Research International, vol. 2014, Article ID 761264, 19 pages, 2014.

Oxidative Stress, Prooxidants, and Antioxidants: The Interplay

Academic Editor: Afaf K. El-Ansary
Received19 May 2013
Revised03 Nov 2013
Accepted06 Nov 2013
Published23 Jan 2014


Oxidative stress is a normal phenomenon in the body. Under normal conditions, the physiologically important intracellular levels of reactive oxygen species (ROS) are maintained at low levels by various enzyme systems participating in the in vivo redox homeostasis. Therefore, oxidative stress can also be viewed as an imbalance between the prooxidants and antioxidants in the body. For the last two decades, oxidative stress has been one of the most burning topics among the biological researchers all over the world. Several reasons can be assigned to justify its importance: knowledge about reactive oxygen and nitrogen species production and metabolism; identification of biomarkers for oxidative damage; evidence relating manifestation of chronic and some acute health problems to oxidative stress; identification of various dietary antioxidants present in plant foods as bioactive molecules; and so on. This review discusses the importance of oxidative stress in the body growth and development as well as proteomic and genomic evidences of its relationship with disease development, incidence of malignancies and autoimmune disorders, increased susceptibility to bacterial, viral, and parasitic diseases, and an interplay with prooxidants and antioxidants for maintaining a sound health, which would be helpful in enhancing the knowledge of any biochemist, pathophysiologist, or medical personnel regarding this important issue.

1. Introduction

Man and animals are exposed to a large number of biological and environmental factors like alterations in feed and husbandry practices, climatic variables, transportation, regrouping, the therapeutic and prophylactic activities, various stressors, and so forth. The ability of the man and animal to fight against these factors is important for maintenance of their health and productivity. Today, the entire world is witnessing an upsurge in chronic health complications like cardiovascular disease, hypertension, diabetes mellitus, different forms of cancer, and other maladies. Medical surveys suggest that diet may serve as a potential tool for the control of these chronic diseases [1, 2]. Regular chewing of tobacco along with inadequate diet is the most prominent finding to mortality due to lung cancer in USA [3]. Diets rich in fruit and vegetables have been reported to exert a protective effect against a variety of diseases, particularly the cardiovascular disease and cancer [410]. The primary nutrients thought to provide protection afforded by fruit and vegetables are the antioxidants [11, 12]. In an analysis, Potter [13] reviewed 200 epidemiological studies, the majority of which showed a protective effect of increased fruit and vegetable intake and concluded that the high content of polyphenolic antioxidants in fruits and vegetables is probably the main factor responsible for the beneficial effects. This awareness has led to a tremendous increase in the proportion of fruits and vegetables rich in antioxidant molecules on the dining table in the last two decades, but still the risk of chronic health problems refuses to decline, rather it upsurged with an enhanced vigour, giving rise to a very important question—why? If the health associated problems are due to oxidative stress and the dietary constituents are potent antioxidants, then the question of problem arrival should not be there. What happens when these antioxidants reach the body tissues of interest or are there other factors still to be unrevealed?

2. Stress

The term “stress” has been used in physics since unknown time as it appears in the definition of Hooke’s law of 1658, but its first use in the biological science dates back to Sir Hans Selye’s letter to the Editor of Nature in 1936. At that time, it was not accepted, but later on, after the famous address of Hans Selye at the prestigious College of France, it received approval among scientific community, but defining stress again troubled Selye over several years. Today, stress can be defined as a process of altered biochemical homeostasis produced by psychological, physiological, or environmental stressors [14]. Any stimulus, no matter whether social, physiological, or physical, that is perceived by the body as challenging, threatening, or demanding can be labeled as a stressor. The presence of a stressor leads to the activation of neurohormonal regulatory mechanisms of the body, through which it maintains the homeostasis [14]. The overall physiological impact of these factors and the adaptation ability of the body determine the variations in growth, development, productivity, and health status of the animals [1517]. These alterations can be viewed as a consequence of general adaptation syndrome as postulated by Hans Selye [18] and usually return to their normal status once the stimulus has disappeared from the scene. Strong and sustained exposure to stress [16, 19, 20] may result in higher energy negative balance and may ultimately result in reduction in adaptation mechanisms, increase in the susceptibility to infection by pathogens, decline in productivity, and finally a huge economical loss [16, 19, 21].

Many of us puzzle between distress, stress, and oxidative stress. Distress differs from stress, which is a physiological reaction that can lead to an adaptive response [22]. Distress is comparatively difficult to define and generally refers to a state in which an animal cannot escape from or adapt to the external or internal stressors or conditions it experiences resulting in negative effects upon its well-being [22]. Stress leads to adaptation but distress does not. Stress is a commonly used term for oxidative stress. Any alteration in homeostasis leads to an increased production of these free radicals, much above the detoxifying capability of the local tissues [23]. These excessive free radicals then interact with other molecules within cells and cause oxidative damage to proteins, membranes, and genes. In this process they often create more free radicals, sparking off a chain of destruction. Oxidative damage has been implicated in the cause of many diseases such as cardiovascular diseases, neuronal degeneration, and cancer and has an impact on the body’s aging process too. An altered response to the therapeutic agents has also been observed [12]. External factors such as pollution, sunlight, and smoking also trigger the production of free radicals.

Most importantly, stress is one of the basic etiologies of disease [24]. It can have several origins like environmental extremes for example, cold, heat, hypoxia, physical exercise or malnutrition (Figure 1).

On the basis of duration and onset, stress might be acute and chronic stress. The stress due to exposure of cold or heat is generally of acute type and is released with the removal of cause. Similarly, stress due to physical exercises or complete immobilization [25] is also acute in nature. The nutritional and environmental stresses, where the causes persist for a longer period of time, are chronic stress.

2.1. Cold Stress

Cold stress is evident whenever the temperature falls below 18°C and the body experiences severe cold related illness and permanent tissue damage. An acute cold stress (−20°C for 4 hours) in rats causes profound reduction in contraction amplitude with an increase in heart rate in the isolated heart preparations [26]. The decrease in amplitudes is associated with inadequate ATP formation. While changing perfusion of poststress isolated heart, myocardial rigidity further slows down and this seemed to be associated with activated glycolysis. There are no signs of cardiomyocytic lesion after cold stress. Reduced coronary flow is the only abnormal effect of acute cold stress under these conditions. High cardiac resistance to the damaging effect of cold is likely to be related to increased processes of glycolysis and glycogenolysis in the cardiomyocytes. The activity of succinate dehydrogenase also gets elevated indicating the influence of cold stress on the Krebs cycle [27]. Coronary blood flow is also reduced and later on results in an altered basophils activity in the myocardium [28].

2.2. Physical Exercise and Stress

Health benefits of regular physical exercise are undebatable. Both resting and contracting skeletal muscles produce reactive oxygen and nitrogen species (ROS, RNS). Low physiological levels of ROS are generated in the muscles to maintain the normal tone and contractility, but excessive generation of ROS promotes contractile dysfunction resulting in muscle weakness and fatigue [29]. This is perhaps the reason why intense and prolonged exercise results in oxidative damage to both proteins and lipids in the contracting muscle fibers [30].

Regular exercise induces changes in both enzymatic and nonenzymatic antioxidants in the skeletal muscle. Furthermore, oxidants can modulate a number of cell signaling pathways and regulate the expression of multiple genes in eukaryotic cells. This oxidant-mediated change in gene expression involves changes at transcriptional, mRNA stability, and signal transduction levels. The magnitude of exercise-mediated changes in superoxide dismutase (SOD) activity of skeletal muscle increases as a function of the intensity and duration of exercise [31, 32]. Mild physical activity increases nuclear factor-kappa B (NF-κB) activity in the muscle of rats as well as the gene expression for manganese superoxide dismutase (MnSOD) and endothelial nitric oxide synthase (eNOS) [33].

2.3. Chronic Stress

Chronic stress significantly alters limbic neuroarchitecture and function and potentiates oxidative stress [25] and emotionality in rats [34]. Chronic restraining of laboratory animals has been found to increase aggression, potentiate anxiety, and enhance fear conditioning [34]. Chronic immobilization induces anxiety behavior and dendritic hypertrophy in the basolateral amygdala, which persist beyond a recovery period. Restraint of rats causes increased mucin release, as measured by [3H] glucosamine incorporation and goblet cell depletion, prostaglandin E2 (PGE2) secretion, and mast cell activation in colonic explants [35]. Upregulation of the neurotensin precursor mRNA in the paraventricular nucleus of the hypothalamus after immobilization has also been reported [36]. Neurotensin stimulates mucin secretion from human colonic goblet cell line by a receptor mediated mechanism [37].

2.4. Nutritional Stress

Nutrition is one of the most significant external etiologies for oxidative stress including its characteristics, type and quality, ratio of the various nutrients, dietary balance with regard to protein, carbohydrates, fats, macro- and trace elements, and so forth. Feed exercises a considerable influence over the physiological condition and thus the homeostasis of the animal body [16, 19, 3842]. Feeding of endogenous or exogenous antioxidants can sensitively regulate glycolysis and the Warburg effect in hepatoma cells [43]. Fasting induces an increase in total leukocytes counts, eosinophils, and metamyelocytes in the blood profile, accompanied by a decrease in the basophils and monocytes, a typical “stress leukogram” produced in the animal body due to the increased endogenous production of cortisol from the adrenal glands during oxidative stress [16, 19, 3842]. The leukocytosis with neutrophilia associated with fasting may be a consequence of an inflammatory reaction, caused by the direct action of ammonia on the rumen wall [38, 44]. The monocytopenia may be a result of adaptation and defense mechanism undergoing in the body and leads to higher susceptibility to pathogens [21, 45].

Nutritional stress causes adrenal gland hyperfunction and, thus, an increased release of catecholamines in the blood, with a simultaneous inhibition of the production of insulin in the pancreas [20, 38, 4648]. The process of glycogenolysis is observed in the first 24 hours of fasting [20, 39, 4649]. Thereafter, gluconeogenesis from amino acid precursors and lipolysis from glycerol, as well as from lactate through the Cori cycle, maintain a regular supply of glucose. Lactate gets transformed into pyruvate and participates in the gluconeogenesis along with the deaminated amino acids. The increased production of catecholamines (epinephrine and dopamine) owing to fasting results in peripheral vasoconstriction and redistribution in blood which is expressed as erythrocytosis, leukocytosis, and neutrophilia [47].

2.5. Hypoxic Stress

Hypoxia is known to stimulate mitochondria to release ROS (mROS). Under hypoxic conditions, mitochondria participate in a ROS burst generated at complex III of the electron transport chain [50]. Hypoxia and reoxygenation result in reversible derangement of ATPase and architecture of mitochondrial membrane. Cardiac hemodynamic parameters, which decline immediately under hypoxic conditions, recover during reoxygenation [51], but the biochemical and histopathological studies provide a complicated pattern [52]. High CAT (carboxyatractyloside) sensitivity of the ATPase is observed at 5 min of hypoxia. The initial phase in hypoxic perfusion (<15 min) exhibits a steep increase of ADP contents and ATPase activities and a drastic fall of ATP/ADP ratios in mitochondria, as well as in tissues. Furthermore, the number of ATPase particles visible at the inner aspect of mitochondrial membrane decreases. During the second phase of hypoxic perfusion (from 30 min onwards), the count of ATPase particles visible at the inner mitochondrial membrane further decreases. ATPase activities fluctuate, retaining close contact with the membrane during hypoxia. The mitochondrial ultrastructural damage becomes more evident. High-energy phosphates reserves of myocardium could help myocardial cells to maintain their structural integrity [52]. ATP/ADP ratios attain values of almost 1. During reoxygenation (after 30 min of hypoxia), the levels of mitochondrial adenine nucleotides, oxidative phosphorylation rate, and respiratory control index increase within 20 min and then slightly decline again. The ATP/ADP ratio is diminished in the course of reoxygenation. ATPase activity also decreases within 20 min of reoxygenation and the ADP/O ratio reaches control values. The ATPase activity gains its highest sensitivity towards catalase at 10 min of reoxygenation attaining a value similar to that of 5 min of hypoxic perfusion.

3. Stress and Well-Being

Each cell in the human body maintains a condition of homeostasis between the oxidant and antioxidant species [53]. Up to 1–3% of the pulmonary intake of oxygen by humans is converted into ROS [54]. Under conditions of normal metabolism, the continuous formation of ROS and other free radicals is important for normal physiological functions like generation of ATP, various catabolic and anabolic processes and the accompanying cellular redox cycles. However, excessive generation of free radicals can occur due to endogenous biological or exogenous environmental factors, such as chemical exposure, pollution, or radiation.

There are ROS subgroups: free radicals such as superoxide radicals () and nonradical ROS such as hydrogen peroxide (H2O2) [55]. The primary free radicals generated in cells are superoxide () and nitric oxide (NO). Superoxide is generated through either incomplete reduction of oxygen in electron transport systems or as a specific product of enzymatic systems, while NO is generated by a series of specific enzymes (the nitric oxide synthases). Both superoxide and NO are reactive and can readily react to form a series of other ROS and RNS.

Generally, mitochondria are the most important source of cellular ROS where continuous production of ROS takes place [55]. This is the result of the electron transport chain located in the mitochondrial membrane, which is essential for the energy production inside the cell [56, 57]. Additionally, some cytochrome 450 enzymes are also known to produce ROS [58].

4. Biochemical Basis of Stress

Several endogenous cells and cellular components participate in initiation and propagation of ROS (Table 1) [5963].

Leakage of free radicalsMembrane-bound enzymesNADPH oxidase
Electron transport systemsMixed function oxidases

Activation of oxygenSoluble cell constituentsTransition metals, thiol containing proteins, quinine derivatives, epinephrine, metalloproteins, hemeproteins, and flavoproteins
Xenobiotic metabolizing enzymesCyt P450-dependent monooxygenases, Cyt , and NADPH-dependent cytochrome reductases

ROS generation/propagationSoluble cytosolic enzymesXanthine oxidase, superoxide dismutase, catalase
Phagocytic cells Neutrophils, macrophages, and monocytes involved in inflammation, respiratory burst, and removal of toxic molecules
Local ischemiaDamaged blood supply due to injury or surgery

All these factors play a crucial role in maintenance of cellular homeostasis. A stressor works by initiating any of these mechanisms. Oxidative stress occurs when the homeostatic processes fail and free radical generation is much beyond the capacity of the body’s defenses, thus promoting cellular injury and tissue damage. This damage may involve DNA and protein content of the cells with lipid peroxidation of cellular membranes, calcium influx, and mitochondrial swelling and lysis [60, 63, 64]. ROS are also appreciated as signaling molecules to regulate a wide variety of physiology. It was first proposed in the 1990s when hydrogen peroxide was shown to be required for cytokine, insulin, growth factor, activator protein-1 (AP-1), and NF-κB signaling [65, 66]. The role of hydrogen peroxide in promoting phosphatase inactivation by cysteine oxidation provided a likely biochemical mechanism by which ROS can impinge on signaling pathways [67]. The role of ROS in signaling of cytochrome c mediated apoptosis is also well established [68]. ROS can cause reversible posttranslational protein modifications to regulate signaling pathways. A typical example of the beneficial physiological role of free radicals is a molecule of nitric oxide (NO). NO is formed from arginine by the action of NO-synthase (NOS) [69]. NO is produced by constitutive NOS during vasodilating processes (eNOS) or during transmission of nerve impulses (nNOS). In the presence of stressors, NO is produced by catalytic action of inducible NOS (iNOS) and is at higher concentrations [7072]. NO can cause damage to proteins, lipids, and DNA either directly or after reaction with superoxide, leading to the formation of the very reactive peroxynitrite anion (nitroperoxide) ONOO– [7375].

Lipid peroxidation of polyunsaturated lipids is one of the most preferred markers for oxidative stress. The product of lipid peroxidation, malondialdehyde, is easily detected in blood/plasma and has been used as a measure of oxidative stress. In addition, the unsaturated aldehydes produced from these reactions have been implicated in modification of cellular proteins and other constituents [76]. The peroxidized lipid can produce peroxy radicals and singlet oxygen.

5. Physiological Role of Stress

Stress has a significant ecological and evolutionary role and may help in understanding the functional interactions among life history traits [7779]. Stress leads to a number of physiological changes in the body including altered locomotor activity and general exploratory behavior. The physiological role of ROS is associated with almost all of the body processes, for example, with reproductive processes [80]. Since under physiological conditions a certain level of free radicals and reactive metabolites is required, complete suppression of FR formation would not be beneficial [81]. One further beneficial example of ROS seen at low/moderate concentrations is the induction of a mitogenic response.

Stress leads to activation of hypothalamic-pituitary-adrenal axis. The increased endogenous catecholamine release has been observed in cold environmental conditions. The activity of succinate dehydrogenase also gets elevated indicating the influence of ROS as evident in cold environmental conditions [27]. Coronary blood flow is reduced and an altered basophils activity in the myocardium is also observed [28].

Free radicals play an irreplaceable role in phagocytosis as one of the significant microbicidal systems [82], or in several biochemical reactions, for example, hydroxylating, carboxylating, or peroxidating reactions, or in the reduction of ribonucleotides [83]. At present, free radicals and their metabolites are assumed to have important biomodulating activities and a regulatory ability in signal transduction process during transduction of intercellular information [83].

Among the reactive oxygen species, H2O2 best fulfills the requirements of being a second messenger [84]. Its enzymatic production and degradation, along with its functional requirement for thiol oxidation, facilitate the specificity for time and place that are required in signaling. Both the thermodynamic and kinetic considerations support that among different possible oxidation states of cysteine, formation of sulfenic acid derivatives or disulfides can be applicable as thiol redox switches in signaling. H2O2 readily diffuses across biological membranes, and so it is well-suited as a diffusible messenger [85, 86].

In the presence of transition metals such as iron or copper, H2O2 can give rise to the indiscriminately reactive and toxic hydroxyl radical (HO) by Fenton chemistry. Increasing evidence indicates that H2O2 is a particularly an intriguing candidate as an intracellular and intercellular signaling molecule because it is neutral and membrane permeable [84, 87].

Specifically, H2O2 can oxidize thiol (–SH) of cysteine residues and form sulphenic acid (–SOH), which can get glutathionylated (–SSG), form a disulfide bond (–SS–) with adjacent thiols, or form a sulfenyl amide (–SN–) with amides [88]. Each of these modifications modifies the activity of the target protein and thus its function in a signaling pathway. Phosphatases appear to be susceptible to regulation by ROS in this manner, as they possess a reactive cysteine moiety in their catalytic domain that can be reversibly oxidized, which inhibits their dephosphorylation activity [67]. Specific examples of phosphatases known to be regulated in this manner are PTP1b, PTEN, and MAPK phosphatases [89]. Any emotional stress leads to a decrease in sympathetic outflow as well as energy production of the tissues [27].

6. Oxidative Stress

The harmful effect of free ROS and RNS radicals causing potential biological damage is termed oxidative stress and nitrosative stress, respectively [9092]. This is evident in biological systems when there is either an excessive production of ROS/RNS and/or a deficiency of enzymatic and nonenzymatic antioxidants. The redox stress/oxidative stress is a complex process. Its impact on the organism depends on the type of oxidant, on the site and intensity of its production, on the composition and activities of various antioxidants, and on the ability of repair systems [93].

The term “ROS” includes all unstable metabolites of molecular oxygen (O2) that have higher reactivity than O2 like superoxide radical () and hydroxyl radical (HO) and nonradical molecules like hydrogen peroxide (H2O2). These ROS are generated as byproduct of normal aerobic metabolism, but their level increases under stress which proves to be a basic health hazard. Mitochondrion is the major cell organelle responsible for ROS production [50, 57]. It generates ATP through a series of oxidative phosphorylation processes. During this process, one- or two-electron reductions instead of four electron reductions of O2 can occur, leading to the formation of or H2O2, and these species can be converted to other ROS. Other sources of ROS may be reactions involving peroxisomal oxidases [94], cytochrome P-450 enzymes [95], NAD (P)H oxidases [96], or xanthine oxidase [97].

7. Oxidative Stress and Diseases

Today the world is experiencing a rise in age related chronic health diseases like cardiovascular disorders, cancer, and so forth and their associated negative health impacts and mortality/casualty [98101]. Some metabolic diseases like diabetes are also associated with an enhanced level of lipoperoxidation (Figure 2).

The central nervous system (CNS) is extremely sensitive to free radical damage because of a relatively small total antioxidant capacity. The ROS produced in the tissues can inflict direct damage to macromolecules, such as lipids, nucleic acids, and proteins [102]. The polyunsaturated fatty acids are one of the favored oxidation targets for ROS. Oxygen-free radicals, particularly superoxide anion radical (), hydroxyl radical (OH•−), and alkylperoxyl radical (OOCR), are potent initiators of lipid peroxidation, the role of which is well established in the pathogenesis of a wide range of diseases. Once lipid peroxidation is initiated, a propagation of chain reactions will take place until termination products are produced. Therefore, end products of lipid peroxidation, such as malondialdehyde (MDA), 4-hydroxy-2-nonenol (4-HNE), and F2-isoprostanes, are accumulated in biological systems. DNA bases are also very susceptible to ROS oxidation, and the predominant detectable oxidation product of DNA bases in vivo is 8-hydroxy-2-deoxyguanosine. Oxidation of DNA bases can cause mutations and deletions in both nuclear and mitochondrial DNA. Mitochondrial DNA is especially prone to oxidative damage due to its proximity to a primary source of ROS and its deficient repair capacity compared with nuclear DNA. These oxidative modifications lead to functional changes in various types of proteins (enzymatic and structural), which can have substantial physiological impact. Similarly, redox modulation of transcription factors produces an increase or decrease in their specific DNA binding activities, thus modifying the gene expression.

Among different markers of oxidative stress, malondialdehyde (MDA) and the natural antioxidants, metalloenzymes Cu, Zn-superoxide dismutase (Cu, Zn-SOD), and selenium dependent glutathione peroxidase (GSHPx), are currently considered to be the most important markers [103106]. Malondialdehyde (MDA) is a three-carbon compound formed from peroxidized polyunsaturated fatty acids, mainly arachidonic acid. It is one of the end products of membrane lipid peroxidation. Since MDA levels are increased in various diseases with excess of oxygen free radicals, many relationships with free radical damage were observed.

Cu, Zn-SOD is an intracellular enzyme present in all oxygen-metabolizing cells, which dismutates the extremely toxic superoxide radical into potentially less toxic hydrogen peroxide. Cu, Zn-SOD is widespread in nature, but being a metalloenzyme, its activity depends upon the free copper and zinc reserves in the tissues. GSHPx, an intracellular enzyme, belongs to several proteins in mammalian cells that can metabolize hydrogen peroxide and lipid hydroperoxides.

8. Oxidative Stress and Altered Immune Function

The relationship between oxidative stress and immune function of the body is well established. The immune defense mechanism uses the lethal effects of oxidants in a beneficial manner with ROS and RNS playing a pivotal role in the killing of pathogens. The skilled phagocytic cells (macrophages, eosinophils, heterophils), as well as B and T lymphocytes, contain an enzyme, the nicotinamide adenine dinucleotide phosphate (NADPH) oxidase [107, 108], which is responsible for the production of ROS following an immune challenge. At the onset of an immune response, phagocytes increase their oxygen uptake as much as 10–20 folds (respiratory burst). The generated by this enzyme serves as the starting material for the production of a suite of reactive species. Direct evidence also certifies production of other powerful prooxidants, such as hydrogen peroxide (H2O2), hypochlorous acid (HOCl), peroxynitrite (ONOO–), and, possibly, hydroxyl (OH) and ozone (O3) by these cells. Although the use of these highly reactive endogenous metabolites in the cytotoxic response of phagocytes also injures the host tissues, the nonspecificity of these oxidants is an advantage since they take care of all the antigenic components of the pathogenic cell [109].

Several studies have demonstrated the interdependency of oxidative stress, immune system, and inflammation. Increased expression of NO has been documented in dengue and in monocyte cultures infected with different types of viral infections. Increased production of NO has also been accompanied with enhancement in oxidative markers like lipid peroxidation and an altered enzymatic and nonenzymatic antioxidative response in dengue infected monocyte cultures [110]. More specifically, the oxygen stress related to immune system dysfunction seems to have a key role in senescence, in agreement with the oxidation/inflammation theory of aging. Moreover, it has been revealed that reduced NADPH oxidase is present in the pollen grains and can lead to induction of airway associated oxidative stress. Such oxidative insult is responsible for developing allergic inflammation in sensitized animals. There is triggering of production of interleukin (IL)-8 along with proinflammatory cytokines, namely, tumor necrosis factor (TNF)-alpha and IL-6. There is initiation of dendritic cell (DC) maturation that causes significant upregulation of the expression of cluster of differentiation (CD)-80, 86 and 83 with a slight overexpression of CD-40 in the membrane. So altogether, innate immunity locally may be alleviated due to oxidative stress induced by exposure to pollen. This in turn helps in participation to initiate adaptive immune response to pollen antigens [111].

The immune status directly interplays with disease production process. The role of physical and psychological stressors contributes to incidences and severity of various viral and bacterial infections. Both innate as well as acquired immune responses are affected by the altered IFN-γ secretion, expression of CD14, production of the acute-phase proteins, and induction of TNF-α. Fatal viral diseases produce severe oxidative stress (OS) leading to rigorous cellular damage. However, initiation, progress, and reduction of damages are governed by the redox balance of oxidation and antioxidation. The major pathway of pathogenesis for cell damage is via lipid peroxidation particularly in microsomes, mitochondria, and endoplasmic reticulum due to OS and free radicals [112, 113]. All the factors responsible for the oxidative stress directly or indirectly participate in immune system defense mechanism. Any alteration leading to immunosuppression can trigger the disease production (Table 2).

Sl. numberDiseaseOrgans involvedEtiologyReferences

(1)Macular degenerationEyesReactive oxygen intermediates (ROI)[206]
(2)DiabetesMulti-organSuperoxide dismutase, catalase, glutathione reductase, glutathione peroxidase[207]
(3)Chronic fatigueMultiorganC-reactive protein[208]
(4)AtherosclerosisBlood vesselsReduced NADPH oxidase system[209]
(5)Autoimmune disorders (systemic lupus erythematosus)Immune system ribonucleoprotein[118]
(6)Neurodegenerative diseases (Alzheimer’s and Parkinson’s disease)BrainReactive oxygen species (ROS)[210]
(7)AsthmaLungsROS particularly H2O2[211]
(8)Rheumatoid and osteoarthritisJointsRadical oxygen species[212]
(9)NephritisKidneyGlutathione transferase kappa (GSTK 1-1)[213]
(10)MelanomaSkinPathophysiological processes including DNA damage and lipid peroxidation (LPO)[214]
(11)Myocardial infarctionHeartReactive oxygen species (ROS)[215]

9. Oxidative Stress and Incidence of Autoimmune Diseases

Oxidative stress can induce production of free radicals that can modify proteins. Alterations in self-antigens (i.e., modified proteins) can instigate the process of autoimmune diseases [114, 115]. Under oxidative stress, cells may produce an excess of ROS/RNS which react with and modify lipids and proteins in the cell [116]. The end products of these reactions may be stable molecules such as 3-chlorothyrosine and 3-nitrotyrosine that may not only block natural biotransformations of the tyrosine like phosphorylation but also change the antigenic profile of the protein. The oxidative modification of the proteins not only changes the antigenic profile of latter but also enhances the antigenicity as well [117]. There exist several examples of autoimmune diseases resulting from oxidative modifications of self-proteins, namely, systemic lupus erythematosus (60 kD Ro ribonucleoprotein) [118], diabetes mellitus (high molecular weight complexes of glutamic acid decarboxylase) [119], and diffuse scleroderma (oxidation of beta-2-glycoprotein) [120, 121].

Moreover, oxidative stress poses an additional threat to the target tissues as in the case of insulin-producing beta cells in the islet of Langerhans [122]. To add to this, autoimmune diseases often occur only in a single tissue irrespective of the fact that other tissues also contain the same antigen but perhaps lack the level of oxidative stress required to initiate the process. This pathological autoreactivity targeted towards redox-modified self-antigens and diagnostic assays designed to measure its cross-reactivity to normal self-antigens further complicate the detection of autoimmune diseases [123]. In the development of autoimmune disease pathogenesis, there is possibly role of psychological stress along with major hormones that are related to stress. It is thereby presumed that the neuroendocrine hormones triggered by stress lead to dysregulation of the immune system ultimately resulting in autoimmune diseases by alteration and amplification of production of cytokine [124].

10. Oxidative Stress and Altered Susceptibility to Bacterial, Viral, and Parasitic Infections

All pathogens, irrespective of their classification, bacterial, viral, or parasitic, with impaired antioxidant defenses show increased susceptibility to phagocytic killing in the host tissues, indicating a microbicidal role of ROS [80]. Vice versa to this, different studies have proven that individuals deficient in antioxidative mechanism are more susceptible to severe bacterial and fungal infections as in case of HIV infections [125]. Reactive species are important in killing pathogens but as a negative side effect can also injure the host tissues (immunopathology). This is particularly apparent during chronic inflammation, which may cause extensive tissue damage with a subsequent burst in oxidative stress [126]. The production of free radicals involves macrophages and neutrophils to combat the invading microbes. The whole of the process is performed in host cells during the activation of phagocytes or the effect of bacteria, virus, parasites, and their cell products reactivity with specific receptors. The multicomponent flavoprotein NADPH oxidase plays vital role in inflammatory processes by catalyzing the production of superoxide anion radical and excessive production of reactive oxygen species (ROS) leads to cellular damage. These cellular damages in general lead to altering immune response to microbes and ultimately altered susceptibility to bacterial, viral, and parasitic infections [127].

11. Oxidative Stress and Increase in Levels of Incidence and Prevalence of Various Malignancies

Carcinogenesis can be defined as a progressive erosion of interactions between multiple activating and deactivating biological activities (both immune and nonimmune) of host tissue resulting in progressive loss of integrity of susceptible tissues. The primitive steps in development of cancer, mutation, and ageing are the result of oxidative damage to the DNA in a cell. A list of oxidized DNA products has been identified currently which can lead to mutation and cancer. Major change noticed due to ROS caused DNA damage is the break in the DNA strand, due to the alterations in the purine or pyrimidine ring [56, 66]. Alongside with ROS other redox metals also play a critical role in development of ageing, mutation, and tumour [128]. In regular cellular mechanism, free radicals scavenger vitamin E, C and glutathione along with enzymes like catalase, peroxidases, and superoxide dismutase control the mechanism of DNA repair. These damages are either in the form of single strand breaks (SSBs), double strand breaks (DSBs), or oxidatively generated clustered DNA lesions (OCDLs). Irregular repair or absence of repair of damaged DNA due to OS might lead to mutagenesis and genetic transformation along with alteration in apoptotic pathway [129].

Oxidative stress produced due to unresolved and persistent inflammation can be a major factor involved in the change of the dynamics of immune responses. These alterations can create an immunological chaos that could lead to loss of architectural integrity of cells and tissues ultimately leading to chronic conditions or cancers [130]. Oxidative stress is reported to be the cause of induction of allergies, autoimmune or neurodegenerative diseases along with altered cell growth, chronic infections leading to neoplasia, metastatic cancer, and angiogenesis [131]. Damage to the cellular components such as proteins, genes, and vasculature is behind such alterations. Moreover, further accumulation of confluent, useless, and complex cells causes additional oxidative stress and maintains continuous activation of immune system and unanswered inflammation [132]. Tissue necrosis and cellular growth are stimulated by coexpression of inflammatory mediators due to oxidative stress-induced altered activity of the cells of the immune system. Such changes of tissue function are mainly responsible for autoimmune, neurodegenerative, and cancerous conditions [133, 134]. Various factors produced due to oxidative stress along with excessively produced wound healing and apoptotic factors, namely, TNF, proteases, ROSs, and kinases, actively participate in tumor growth and proliferation. These factors are also required for the membrane degradation, invasion of neighboring tissues, and migration of tumor cells through vasculature and lymphatic channels for metastasis [135137]. The incidences of thyroid cancers have increased in the last decades worldwide which is most likely due to exposure of human population in mass to radiation causing increased free radical generation [138].

12. Oxidative Stress and Aging

Aging is an inherent mechanism existing in all living cells. There is a decline in organ functions progressively along with the age-related disease development. The two most important theories related to ageing are free radical and mitochondrial theories, and these have passed through the test of time. There is claim by such theories that a vicious cycle is generated within mitochondria wherein reactive oxygen species (ROS) is produced in increased amount thereby augmenting the damage potential [139]. Oxidative stress is present at genetic, molecular, cellular, tissue, and system levels of all living beings and is usually manifested as a progressive accumulation of diverse deleterious changes in cells and tissues with advancing age that increase the risk of disease and death [140]. Recent studies have shown that with age, ROS levels show accumulation in major organ systems such as liver, heart, brain, and skeletal muscle [141145] either due to their increased production or reduced detoxification. Thus, aging may be referred to as a progressive decline in biological function of the tissues with respect to time as well as a decrease in the adaptability to different kinds of stress or briefly an overall increase in susceptibility to diseases [146]. Oxidative stress theory is presently the most accepted explanation for the aging which holds that increases in ROS lead to functional alterations, pathological conditions and other clinically observable signs of aging, and finally death [147]. No matter whether mitochondrial DNA damage is involved or electron transport chain damage is responsible for aging, modulation of cellular signal response to stress or activation of redox-sensitive transcriptional factors by age-related oxidative stress causes the upregulation of proinflammatory gene expression, finally leading to an increase in the ROS levels [146].

13. Genomic Evidences of the Stress-Disease Development Interrelationship

Persistent oxidative stress due to altered inflammation acts as precancerous state of host cells leading to the initiation of genetic mutations, genetic errors, epigenetic abnormalities, wrongly coded genome, and impaired regulation of gene expression [148]. Events like methylation of nucleic acid, binding of DNA proteins, formation and binding of histone proteins, function of repair, and enzyme mediated modifications are sensitive to free radicals formed during oxidative stress [149]. These events involved in epigenetic modification and telomere-telomerase pathways can induce mutations of suppressor genes [150]. The suppression of genes alters somatic maintenance and repair leading to altered proliferative control of gene expression, polymorphism, and contact inhibition regulation and telomere shortening [151]. The activation or progressive transformation of cancer cells is also augmented by inactivated or mutated suppressor gene pathways. Moreover, abnormal DNA methylation of CpG and various enzymatic pathways influence inflammation and carcinogenesis [152]. The theory of modus operandi for pathogenesis of vitiligo, a multifactorial polygenic disorder, also moves around autoimmune, cytotoxic, oxidant-antioxidant, and neural mechanisms [153].

Lipid originated atherosclerosis also involves endoplasmic reticulum (ER) stress in macrophages. ER stress mitigation with a chemical chaperone leads to massive protection against macrophage associated lipotoxic death. This causes prevention of expression of macrophage-fatty acid-binding protein-4 (aP2). There is also an increase in the phospholipid (rich in monounsaturated fatty acid as well as bioactive lipids) production due to absence of lipid chaperones. There is also further impact of aP2 on metabolism of lipid in the macrophages. The stress response in ER is also mediated by key lipogenic enzymes upregulation in the liver [154]. Similarly, OS due to alcohol toxicity triggers the release of certain cytokines to activate collagen gene expression in liver stellate cells leading to progression of liver fibrosis [155].

14. Proteomic Evidences of the Stress-Disease Development Interrelationship

Oxidative damages mediated by free radicals lead to protein modification and ultimately cellular damages and disease pathogenesis. There lies equilibrium between the antioxidants level and cellular prooxidants under normal conditions of physiology. But when there is occurrence of environmental factors or stressors, there exists an imbalance in the homeostasis which is in favour of prooxidants. This results in the oxidative stress phenomenon [156]. An antioxidant deficiency can also result in oxidative stress leading to generation of reactive oxygen or nitrogen species in excess [157]. The 20S proteosome often removes the proteins that are damaged oxidatively. The proteosome systemic defects result in increased levels of proteins that are oxidatively modified along with development of neurotoxicity [158162]. For instance, oxidation of nucleic acid and protein along with peroxidation of lipid is highest and most severe in the hippocampus of the brain, which is involved in the processing of memory along with cognitive function [158, 159]. Such study is strongly suggestive of the fact that a primary event in the Alzheimer’s disease development is an oxidative stress [163]. These alterations and modifications in proteomes elicit antibodies formation in diseases like rheumatoid arthritis (RA), diabetes mellitus (DM), and systemic lupus erythematosus [164].

15. Assessment of Oxidative Stress

The concentration of different reductant-oxidant markers is considered an important parameter for assessing the prooxidant status in the body tissues [83]. Several indicators of in vivo redox status are available, including the ratios of GSH to GSSG, NADPH to , and NADH to , as well as the balance between reduced and oxidized thioredoxin. Out of these redox pairs, the GSH-to-GSSG ratio is thought to be one of most abundant redox buffer systems in mammalian species [93]. A decrease in this ratio indicates a relative shift from a reduced to an oxidized form of GSH, suggesting the presence of oxidative stress at the cellular or tissue level. In aging, an age-related shift from a redox balance to an oxidative profile is observed which results in a reduced ability to buffer ROS that are generated in both “normal” conditions and at times of challenge [23, 83, 93, 147]. Thus, a progressive shift in cellular redox status could potentially be one of the primary molecular mechanisms contributing to the aging process and accompanying functional declines.

16. Prooxidants

Prooxidant refers to any endobiotic or xenobiotic that induces oxidative stress either by generation of ROS or by inhibiting antioxidant systems. It can include all reactive, free radical containing molecules in cells or tissues. Prooxidants may be classified into several categories (Table 3).

Sl. numberClass ExamplesMechanism

(1)DrugsCommon over-the-counter drug like analgesic (paracetamol) or anticancerous drug (methotrexate)ROS generation leading to alterations in macromolecules which finally can fatally damage the tissues mainly liver and kidney

(2)Transition metalsMagnesium, iron, copper, zinc, and so forthThese metals induce Fenton reaction and Haber-Weiss reaction leading to generation of excessive ROS. Chronic magnesium is a classic prooxidant disease. The other can be hemochromatosis due to high iron levels or Wilson disease due to copper

(3)PesticideBHC, DDT, and so forthStimulation of free radical production, induction of lipid peroxidation, alterations in antioxidant enzymes and the glutathione redox system

(4)Physical exerciseRunning, weight liftingRelaxationcontraction of muscle involves production of ROS. Rigorous exercise leads to excessive ROS

(5)Mental anxietyTension, apprehensionImbalance in the redox system plays a role in neuroinflammation and neurodegeneration, mitochondrial dysfunction, altered neuronal signaling, and inhibition of neurogenesis

(6)PathophysiologyLocal ischemiaGives rise to increased ROS generation

(7)Environmental factorExtreme weather (heat, cold, thunderstorm)During adaptation, mitochondrial membrane fluidity decreases which may disrupt the transfer of electrons, thereby increasing the production of ROS

(8)Antioxidants Ascorbic acid, vitamin E, polyphenolsAct as prooxidant under certain circumstances, for example, heavy metals

Some of the popular and well known antioxidant flavonoids have been reported to act as prooxidant also when a transition metal is available [165]. These have been found to be mutagenic in vitro [102, 166168]. The antioxidant activities and the copper-initiated prooxidant activities of these flavonoids depend on their structures. The OH substitution is necessary for the antioxidant activity of a flavonoid [169]. Flavone and flavanone, which have no OH substitutions and which provide the basic chemical structures for the flavonoids, show neither antioxidant activities nor copper-initiated prooxidant activities. The copper initiated prooxidant activity of a flavonoid also depends on the number of free OH substitutions on its structure [170]. The more the OH substitutions, the stronger the prooxidant activity. O-Methylation and probably also other O-modifications of the flavonoid OH substitutions inactivate both the antioxidant and the prooxidant activities of the flavonoids.

The antioxidant activity of quercetin has been found to be better than its monoglucosides in a test system wherein lipid peroxidation was facilitated by aqueous oxygen radicals [171]. Luteolin has also proved to be a significantly stronger antioxidant than its two glycosides [172].

Flavonoids generally occur in foods as O-glycosides with sugars bound at the C3 position. Methylation or glycosidic modification of the OH substitutions leads to inactivation of transition metal-initiated prooxidant activity of a flavonoid.

The protection provided by fruits and vegetables against diseases, including cancer and cardiovascular diseases, has been attributed to the various antioxidants, including flavonoids, contained in these foods. Flavonoids, such as quercetin and kaempferol, induce nuclear DNA damage and lipid peroxidation in the presence of transition metals. The in vivo copper-initiated prooxidant actions of flavonoids and other antioxidants including ascorbic acid and α-tocopherol are generally not considered significant, as copper ion will be largely sequestered in the tissues, except in case of metal toxicity. The prevention of iron-induced lipid peroxidation in hepatocytes by some flavonoids including quercetin is well known [49, 173].

17. Antioxidants

To counteract the harmful effects taking place in the cell, system has evolved itself with some strategies like prevention of damage, repair mechanism to alleviate the oxidative damages, physical protection mechanism against damage, and the final most important is the antioxidant defense mechanisms. Based on the oxidative stress related free radical theory, the antioxidants are the first line of choice to take care of the stress. Endogenous antioxidant defenses include a network of compartmentalized antioxidant enzymic and nonenzymic molecules that are usually distributed within the cytoplasm and various cell organelles. In eukaryotic organisms, several ubiquitous primary antioxidant enzymes, such as SOD, catalase, and several peroxidases catalyze a complex cascade of reactions to convert ROS to more stable molecules, such as water and O2. Besides the primary antioxidant enzymes, a large number of secondary enzymes act in close association with small molecular-weight antioxidants to form redox cycles that provide necessary cofactors for primary antioxidant enzyme functions. Small molecular-weight nonenzymic antioxidants (e.g., GSH, NADPH, thioredoxin, vitamins E and C, and trace metals, such as selenium) also function as direct scavengers of ROS. These enzymatic and nonenzymatic antioxidant systems are necessary for sustaining life by maintaining a delicate intracellular redox balance and minimizing undesirable cellular damage caused by ROS [83]. Endogenous and exogenous antioxidants include some high molecular weight (SOD, GPx, Catalse, albumin, transferring, metallothionein) and some low molecular weight substances (uric acid, ascorbic acid, lipoic acid, glutathione, ubiquinol, tocopherol/vitamin E, flavonoids).

Natural food-derived components have received great attention in the last two decades, and several biological activities showing promising anti-inflammatory, antioxidant, and anti-apoptotic-modulatory potential have been identified [17, 174, 175]. Flavonoids comprise a large heterogeneous group of benzopyran derivatives present in fruits, vegetables, and herbs. They are secondary plant metabolites and more than 4000 molecular species have been described. Flavonoids exert a positive health effect in cancer and neurodegenerative disorders, owing to their free radical-scavenging activities [169]. One of the most abundant natural flavonoids present in a large number of fruits and vegetables is quercetin (3,5,7,3′,4′, pentahydroxyflavone) which prevents oxidative injury and cell death by scavenging free radicals, donating hydrogen compound, quenching singlet oxygen, and preventing lipid peroxidation or chelating metal ions [176]. Red wines also have a high content of phenolic substances including catechin and resveratrol [177], which are responsible for the antioxidant action, anti-inflammatory, antiatherogenic property, oestrogenic growth-promoting effect, and immunomodulation. Recently, the potential of resveratrol as an antiaging agent in treating age-related human diseases has also been proven.

18. Interplay of Antioxidative and Prooxidative Role of Antioxidants

Ascorbic acid has both antioxidant and prooxidant effects, depending upon the dose [178]. Low electron potential and resonance stability of ascorbate and the ascorbyl radical have enabled ascorbic acid to enjoy the privilege as an antioxidant [179, 180]. In ascorbic acid alone treated rats, ascorbic acid has been found to act as a CYP inhibitor. Similar activity has also been observed for other antioxidants-quercetin [181] and chitosan oligosaccahrides [182], which may act as potential CYP inhibitors. Specifically, Phase I genes of xenobiotic biotransformation, namely, CYP1A1, CYP2E1, and CYP2C29, have been previously reported to be downregulated in female rats in the presence of a well known antioxidant, resveratrol [183]. The antioxidant and prooxidant role of ascorbic acid in low (30 and 100 mg/kg body weight) and high doses (1000 mg/kg body weight), respectively, has also been reported in case of ischemia induced oxidative stress [178]. The in vivo prooxidant/antioxidant activity of betacarotene and lycopene has also been found to depend on their interaction with biological membranes and the other co-antioxidant molecules like vitamin C or E [184]. At higher oxygen tension, carotenoids tend to lose their effectiveness as antioxidants. In a turn around to this, the prooxidant effect of low levels of tocopherol is evident at low oxygen tension [185].

Moreover, α-lipoic acid exerts a protective effect on the kidney of diabetic rats but a prooxidant effect in nondiabetic animals [186]. The prooxidant effects have been attributed to dehydroxylipoic acid (DHLA), the reduced metabolite of α-lipoic acid owing to its ability to reduce iron, initiate reactive sulfur-containing radicals, and thus damage proteins such as alpha 1-antiproteinase and creatine kinase playing a role in renal homeostasis [186]. An increase in α-lipoic acid and DHLA-induced mitochondrial and submitochondrial production in rat liver [187] and NADPH-induced and expression of p47phox in the nondiabetic kidney has also been observed [186].

Withaferins, the pharmacological molecules of Withania somnifera L. Dunal (commonly known as Ashwagandha), have been used safely for thousands of years in Ayurvedic medicine practice for the treatment of various disorders [188191]. In the last 5–10 years, numerous reports revealed the proapoptotic effects of withaferins [192198]. Withaferins can also initiate apoptosis and prevent metastasis of breast carcinomas under the influence of interleukin-6-induced activation and transcription [176] and prove to be of tremendous clinical benefit to human patients. In accordance to these reports, recently withaferin-induced apoptosis has been found to be mediated by ROS production due to inhibition of mitochondrial respiration [199].

Use of ginseng and Eleutherococcus senticosus is thought to increase the body’s capacity to tolerate external stresses, leading to increased physical or mental performance [200]. Although an extensive literature documenting adaptogenic effects in laboratory animal systems exists, results from human clinical studies are conflicting and variable [200202]. However, there is evidence that extracts of ginseng and Eleutherococcus sp. can have an immunostimulatory effect in humans, and this may contribute to the adaptogen or tonic effects of these plants [200, 203]. From laboratory studies, it has been suggested that the pharmacological target sites for these compounds involve the hypothalamus-pituitary-adrenal axis due to the observed effects upon serum levels of adrenocorticotropic hormone and corticosterone [202]. However, it should also be noted that the overall effects of the ginsenosides can be quite complex due to their potential for multiple actions even within a single tissue [201].

The flavonoids present in ginkgo extracts exist primarily as glycosylated derivatives of kaempferol and quercetin [203205]. These flavonoid glycosides have been shown to be extremely effective free radical scavengers [201, 202, 205]. It is believed that the collective action of these components leads to a reduction in damage and improved functioning of the blood vessels [200, 202].

Depending on the type and level of ROS and RNS, duration of exposure, antioxidant status of tissues, exposure to free radicals and their metabolites leads to different responses—increased proliferation, interrupted cell cycle, apoptosis, or necrosis [165]. A typical example is a hydrophilic antioxidant, ascorbic acid (vitamin C). Ascorbic acid reacts with free radicals to produce semidehydro- or dehydroascorbic acids (DHA). DHA is then regenerated by antioxidant enzymes present in the organism (semidehydroascorbic acid reductase and dehydroascorbic acid reductase) back to the functional ascorbate. In the presence of ions of transition metals, ascorbic acid reduces them and it gets oxidized to DHA. Hydrogen peroxide formed in the reaction further reacts with reduced metal ions leading to generation of hydroxyl radical through Fenton type reaction. Iron ions practically never occur in the free form in the tissues; therefore, the occurrence of Fenton type reaction in vivo is not likely.

Recently, toxicity of ascorbic acid has also been attributed to its autooxidation. Ascorbic acid can be oxidized in the extracellular environment in the presence of metal ions to dehydroascorbic acid, which is transported into the cell through the glucose transporter (GLUT). Here it is reduced back to ascorbate. This movement of electrons changes the redox state of the cell influencing gene expression.

19. Conclusions

Oxidative stress is nothing but the imbalance between oxidants and antioxidants in favor of the oxidants which are formed as a normal product of aerobic metabolism but during pathophysiological conditions can be produced at an elevated rate. Both enzymatic and nonenzymatic strategies are involved in antioxidant defense, and antioxidant efficacy of any molecule depends on the cooxidant. Well proven free radical scavengers can be prooxidant unless linked to a radical sink. Moreover, as the free radicals share a physiological as well as pathological role in the body, the same antioxidant molecule just due to its free radical scavenging activity may act as disease promoter, by neutralizing the physiologically desired ROS molecules, and as disease alleviator by removing the excessive levels of ROS species. The importance of several vitamins like vitamin A and tocopherols as well as carotenes, oxycarotenoids, and ubiquinols in their lipid phase has been understood in recent years. Low molecular mass antioxidant molecules that include nuclear as well as mitochondrial matrices, extracellular fluids, and so forth have been studied vividly to understand how they accelerate the body defense significantly. Protection from the influence of oxidants being an important issue has become the centre of attraction of the scientists and various research groups in recent years to understand the mechanism of action of various antioxidants present in herbs as well as fruits and vegetables that can act as antiaging agents as well. There has been ever increasing knowledge in the role of oxygen derived prooxidants and antioxidants that play crucial role in both normal metabolism and several clinical disease states. Advances in the field of biochemistry including enzymology have led to the use of various enzymes as well as endogenous and exogenous antioxidants having low molecular weight that can inhibit the harmful effect of oxidants. Still much research works are needed to understand the antioxidant status of any organ that is susceptible to oxidative stress induced damage particularly the involvement of genetic codes and gene protein interaction. Understanding of genetic alterations and molecular mechanism is certainly helping out to reveal the interaction of free radicals and their role in proteomics, genomics and disease development process. Moreover, the prooxidant or antioxidant behavior of the universally accepted antioxidant molecules is now duly expressed in term of dependence upon the actual molecular conditions prevailing in the tissues.

Nevertheless, other environmental factors like oxygen tension, concentration of transition metals along with their redox status will also be a deciding factor. Thus, it can be concluded that a thorough knowledge of biochemistry and general chemistry will help the researchers to explore more the interplay between oxidative stress, prooxidants, and antioxidants.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.


  1. A. Kumar, A. Rahal, S. K. Diwedi, and M. K. Gupta, “Bacterial prevalence and antibiotic resistance profile from bovine mastitis in Mathura, India,” Egyptian Journal of Dairy Sciences, vol. 38, no. 1, pp. 31–34, 2010. View at: Google Scholar
  2. A. Kumar, A. Rahal, and A. K. Verma, “In-Vitro antibacterial activity of hot aqueous extract (HAE) of Ocimum sanctum (Tulsi) leaves,” Indian Journal of Veterinary Medicine, vol. 36, no. 2, pp. 75–76, 2011. View at: Google Scholar
  3. J. M. McGinnis and W. H. Foege, “Actual causes of death in the United States,” Journal of the American Medical Association, vol. 270, no. 18, pp. 2207–2212, 1993. View at: Publisher Site | Google Scholar
  4. Mahima, A. Rahal, R. Deb et al., “Immunomodulatory and therapeutic potentials of herbal, traditional/indeginous and ethnoveterinary medicines,” Pakistan Journal of Biological Sciences, vol. 15, no. 16, pp. 754–774, 2012. View at: Publisher Site | Google Scholar
  5. A. H. Ahmad, A. Rahal, and A. Tripathi, “Optimising drug potential of plants,” in Proceedings of the 6th Annual Conference of the Recent Trends in Development of Herbal Drugs: Challenges and Opportunities (ISVPT '06), pp. 23–25, Bihar, India, 2006. View at: Google Scholar
  6. A. H. Ahmad, A. Rahal, and N. Siddiqui, “Bioprospecting of medicinal plants,” in Proceedings of the National Conference on Increasing Production and Productivity of Medicinal and Aromatic Plants Through Traditional Practices, Department of Plant Pathology, College of Agriculture, GBPUA&T, Uttrakhand, India, September 2008. View at: Google Scholar
  7. M. W. Gillman, L. A. Cupples, D. Gagnon et al., “Protective effect of fruits and vegetables on development of stroke in men,” Journal of the American Medical Association, vol. 273, no. 14, pp. 1113–1117, 1995. View at: Google Scholar
  8. K. J. Joshipura, A. Ascherio, J. E. Manson et al., “Fruit and vegetable intake in relation to risk of ischemic stroke,” Journal of the American Medical Association, vol. 282, no. 13, pp. 1233–1239, 1999. View at: Publisher Site | Google Scholar
  9. B. D. Cox, M. J. Whichelow, and A. T. Prevost, “Seasonal consumption of salad vegetables and fresh fruit in relation to the development of cardiovascular disease and cancer,” Public Health Nutrition, vol. 3, no. 1, pp. 19–29, 2000. View at: Google Scholar
  10. E. Strandhagen, P.-O. Hansson, I. Bosaeus, B. Isaksson, and H. Eriksson, “High fruit intake may reduce mortality among middle-aged and elderly men. The study of men born in 1913,” European Journal of Clinical Nutrition, vol. 54, no. 4, pp. 337–341, 2000. View at: Publisher Site | Google Scholar
  11. M. A. Eastwood, “Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease?” QJM, vol. 92, no. 9, pp. 527–530, 1999. View at: Google Scholar
  12. A. Rahal, A. H. Ahmad, A. Kumar et al., “Clinical drug interactions: a holistic view,” Pakistan Journal of Biological Sciences, vol. 16, no. 16, pp. 751–758, 2013. View at: Google Scholar
  13. J. D. Potter, “Cancer prevention: epidemiology and experiment,” Cancer Letters, vol. 114, no. 1-2, pp. 7–9, 1997. View at: Publisher Site | Google Scholar
  14. N. T. Dimitrios, K. C. Geogrios, and I. X. H. Dmitrios, “Neurohormonal hypothesis in heart failure,” Hellenic Journal of Cardiology, vol. 44, no. 3, pp. 195–205, 2003. View at: Google Scholar
  15. K. Lundgren, K. Kalev, G. A. O. Chuansi, and H. Ingvar, “Effects of heat stress on working populations when facing climate change,” Industrial Health, vol. 51, pp. 3–15, 2013. View at: Publisher Site | Google Scholar
  16. M. D. Kock, D. A. Jessup, R. K. Clark, and C. E. Franti, “Effects of capture on biological parameters in free-ranging bighorn sheep (Ovis canadensis): evaluation of drop-net, drive-net, chemical immobilization and the net-gun,” Journal of Wildlife Diseases, vol. 23, no. 4, pp. 641–651, 1987. View at: Google Scholar
  17. J. R. S. Hoult, M. A. Moroney, and M. Paya, “Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase,” Methods in Enzymology, vol. 234, pp. 443–454, 1994. View at: Publisher Site | Google Scholar
  18. M. Y. Akhalaya, A. G. Platonov, and A. A. Baizhumanov, “Short-term cold exposure improves antioxidant status and general resistance of animals,” Bulletin of Experimental Biology and Medicine, vol. 141, no. 1, pp. 26–29, 2006. View at: Publisher Site | Google Scholar
  19. M. D. Kock, R. K. Clark, C. E. Franti, D. A. Jessup, and J. D. Wehausen, “Effects of capture on biological parameters in free-ranging bighorn sheep (Ovis canadensis): evaluation of normal, stressed and mortality outcomes and documentation of postcapture survival,” Journal of Wildlife Diseases, vol. 23, no. 4, pp. 652–662, 1987. View at: Google Scholar
  20. R. Ziegler, “Changes in lipid and carbohydrate metabolism during starvation in adult Manduca sexta,” Journal of Comparative Physiology B, vol. 161, no. 2, pp. 125–131, 1991. View at: Publisher Site | Google Scholar
  21. N. Golikov, Adaptation in Farm Animals, Agropromizdat, Sofia, Bulgaria, 1985.
  22. C. Pekow, “Defining, measuring, and interpreting stress in laboratory animals,” Contemporary Topics in Laboratory Animal Science, vol. 44, no. 2, pp. 41–45, 2005. View at: Google Scholar
  23. D. Trachootham, W. Lu, M. A. Ogasawara, N. R. Valle, and P. Huang, “Redox regulation of cell survival,” Antioxidants and Redox Signaling, vol. 10, no. 8, pp. 1343–1374, 2008. View at: Publisher Site | Google Scholar
  24. S. Dhanalakshmi, R. Srikumar, S. Manikandan, N. J. Parthasarathy, and R. S. Devi, “Antioxidant property of triphala on cold stress induced oxidative stress in experimental rats,” Journal of Health Science, vol. 52, no. 6, pp. 843–847, 2006. View at: Publisher Site | Google Scholar
  25. A. Rahal, V. Singh, D. Mehra, S. Rajesh, and A. H. Ahmad, “Prophylactic efficacy of Podophyllum hexandrum in alleviation of immobilization stress induced oxidative damage in rats,” Journal of Natural Products, vol. 2, pp. 110–115, 2009. View at: Google Scholar
  26. I. Lishmanov, T. V. Lasukova, S. A. Afanas'ev, L. N. Maslov, N. M. Krotenko, and N. V. Naryzhnaia, “Effect of cold stress on the contractile activity, carbohydrate and energy metabolism in the isolated rat heart,” Patologicheskaia Fiziologiia i èksperimental'naia Terapiia, no. 1, pp. 28–31, 1997. View at: Google Scholar
  27. V. N. Gurin, V. I. Lapsha, and L. G. Streletskaia, “Changes in the catecholamine level and energy metabolism of the myocardium in rats during cold and emotional stress,” Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova, vol. 75, no. 4, pp. 542–547, 1989. View at: Google Scholar
  28. S. A. Afanas'ev, B. I. Kondrat'ev, E. D. Alekseeva, and I. B. Lishmanov, “Effect of the acute exposure to cold on the heart muscle,” Rossiiskii Fiziologicheskii Zhurnal imeni I.M. Sechenova, vol. 83, no. 4, pp. 98–102, 1997. View at: Google Scholar
  29. S. K. Powers and M. J. Jackson, “Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production,” Physiological Reviews, vol. 88, no. 4, pp. 1243–1276, 2008. View at: Publisher Site | Google Scholar
  30. J. Vina, C. Borras, M. Gomez-Cabrera, and W. C. Orr, “Part of the series: from dietary antioxidants to regulators in cellular signalling and gene expression. Role of reactive oxygen species and (phyto)oestrogens in the modulation of adaptive response to stress,” Free Radical Research, vol. 40, no. 2, pp. 111–119, 2006. View at: Publisher Site | Google Scholar
  31. S. K. Powers, D. Criswell, J. Lawler et al., “Influence of exercise and fiber type on antioxidant enzyme activity in rat skeletal muscle,” American Journal of Physiology, vol. 266, no. 2, pp. R375–R380, 1994. View at: Google Scholar
  32. S. K. Powers, D. Criswell, J. Lawler et al., “Regional training-induced alterations in diaphragmatic oxidative and antioxidant enzymes,” Respiration Physiology, vol. 95, no. 2, pp. 227–237, 1994. View at: Publisher Site | Google Scholar
  33. M. C. Gomez-Cabrera, E. Domenech, and J. Viña, “Moderate exercise is an antioxidant: upregulation of antioxidant genes by training,” Free Radical Biology and Medicine, vol. 44, no. 2, pp. 126–131, 2008. View at: Publisher Site | Google Scholar
  34. G. E. Wood, E. H. Norris, E. Waters, J. T. Stoldt, and B. S. McEwen, “Chronic immobilization stress alters aspects of emotionality and associative learning in the rat,” Behavioral Neuroscience, vol. 122, no. 2, pp. 282–292, 2008. View at: Publisher Site | Google Scholar
  35. I. Castagliuolo, J. T. LaMont, B. Qiu et al., “Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells,” American Journal of Physiology, vol. 271, no. 5, pp. G884–G892, 1996. View at: Google Scholar
  36. S. Ceccatelli, M. Eriksson, and T. Hokfelt, “Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus,” Neuroendocrinology, vol. 49, no. 3, pp. 309–323, 1989. View at: Google Scholar
  37. C. Augeron, T. Voisin, J. J. Maoret, B. Berthon, M. Laburthe, and C. L. Laboisse, “Neurotensin and neuromedin N stimulate mucin output from human goblet cells (Cl.16E) via neurotensin receptors,” American Journal of Physiology, vol. 262, no. 3, pp. G470–G476, 1992. View at: Google Scholar
  38. N. Sandner, M. Stangassinger, and D. Giesecke, “The effect of glucocorticoid on the glucose metabolism of pigmy goats. 1. Selected metabolites of energy metabolism,” Zentralblatt fur Veterinarmedizin A, vol. 37, no. 1, pp. 35–44, 1990. View at: Google Scholar
  39. J. Duhault, F. Lacour, J. Espinal, and Y. Rolland, “Effect of activation of the serotoninergic system during prolonged starvation on subsequent caloric intake and macronutrient selection in the Zucker rat,” Appetite, vol. 20, no. 2, pp. 135–144, 1993. View at: Publisher Site | Google Scholar
  40. T. Ohama, N. Matsuki, H. Saito et al., “Effect of starving and refeeding on lipid metabolism in suncus,” Journal of Biochemistry, vol. 115, no. 2, pp. 190–193, 1994. View at: Google Scholar
  41. I. C. Munch, “Influences of time intervals between meals and total food intake on resting metabolic rate in rats,” Acta Physiologica Scandinavica, vol. 153, no. 3, pp. 243–247, 1995. View at: Google Scholar
  42. H. C. Chung, S. H. Sung, J. S. Kim, Y. C. Kim, and S. G. Kim, “Lack of cytochrome P450 2E1 (CYP2E1) induction in the rat liver by starvation without coprophagy,” Drug Metabolism and Disposition, vol. 29, no. 3, pp. 213–216, 2001. View at: Google Scholar
  43. D. Shi, F. Xie, C. Zhai, J. S. Stern, Y. Liu, and S. Liu, “The role of cellular oxidative stress in regulating glycolysis energy metabolism in hepatoma cells,” Molecular Cancer, vol. 8, p. 32, 2009. View at: Publisher Site | Google Scholar
  44. E. L. Potter and B. A. Dehority, “Effects of changes in feed level, starvation, and level of feed after starvation upon the concentration of rumen protozoa in the ovine,” Applied Microbiology, vol. 26, no. 5, pp. 692–698, 1973. View at: Google Scholar
  45. G. V. Burxer, “Stress in farm animals,” Veterinaria, vol. 8, pp. 92–94, 1974. View at: Google Scholar
  46. H. Peng and M. J. Coon, “Regulation of rabbit cytochrome P450 2E1 expression in HepG2 cells by insulin and thyroid hormone,” Molecular Pharmacology, vol. 54, no. 4, pp. 740–747, 1998. View at: Google Scholar
  47. Y. Yamazoe, N. Murayama, M. Shimada, K. Yamauchi, and R. Kato, “Cytochrome P450 in livers of diabetic rats: regulation by growth hormone and insulin,” Archives of Biochemistry and Biophysics, vol. 268, no. 2, pp. 567–575, 1989. View at: Google Scholar
  48. M. H. Son, K. W. Kang, E. J. Kim et al., “Role of glucose utilization in the restoration of hypophysectomy-induced hepatic cytochrome P450 2E1 by growth hormone in rats,” Chemico-Biological Interactions, vol. 127, no. 1, pp. 13–28, 2000. View at: Publisher Site | Google Scholar
  49. U. Sinsch, R. Seine, and N. Sherif, “Seasonal changes in the tolerance of osmotic stress in natterjack toads (Bufo calamita),” Comparative Biochemistry and Physiology, vol. 101, no. 2, pp. 353–360, 1992. View at: Publisher Site | Google Scholar
  50. Y. Liu, G. Fiskum, and D. Schubert, “Generation of reactive oxygen species by the mitochondrial electron transport chain,” Journal of Neurochemistry, vol. 80, no. 5, pp. 780–787, 2002. View at: Publisher Site | Google Scholar
  51. H. J. Freisleben, H. Kriege, C. Clarke, F. Beyersdorf, and G. Zimmer, “Hemodynamic and mitochondrial parameters during hypoxia and reoxygenation in working rat hearts,” Arzneimittel-Forschung, vol. 41, no. 1, pp. 81–88, 1991. View at: Google Scholar
  52. D. Feuvray, F. James, and J. De Leiris, “Protective effect of endogenous catecholamine depletion against hypoxic and reoxygenation damage in isolated rat heart: an ultrastructural study,” Journal de Physiologie, vol. 76, no. 7, pp. 717–722, 1980. View at: Google Scholar
  53. G. Poli, G. Leonarduzzi, F. Biasi, and E. Chiarpotto, “Oxidative stress and cell signalling,” Current Medicinal Chemistry, vol. 11, no. 9, pp. 1163–1182, 2004. View at: Google Scholar
  54. R. S. Sohal, “Role of oxidative stress and protein oxidation in the aging process,” Free Radical Biology and Medicine, vol. 33, no. 1, pp. 37–44, 2002. View at: Publisher Site | Google Scholar
  55. A. D. Ahmed, C. Hye-Yeon, K. Jung-Hyun, and C. Ssang-Goo, “Role of oxidative stress in stem, cancer, and cancer stem cells,” Cancers, vol. 2, no. 2, pp. 859–884, 2010. View at: Publisher Site | Google Scholar
  56. M. Valko, C. J. Rhodes, J. Moncol, M. Izakovic, and M. Mazur, “Free radicals, metals and antioxidants in oxidative stress-induced cancer,” Chemico-Biological Interactions, vol. 160, no. 1, pp. 1–40, 2006. View at: Publisher Site | Google Scholar
  57. M. Inoue, E. F. Sato, M. Nishikawa et al., “Mitochondrial generation of reactive oxygen species and its role in aerobic life,” Current Medicinal Chemistry, vol. 10, no. 23, pp. 2495–2505, 2003. View at: Publisher Site | Google Scholar
  58. D. V. Parke and A. Sapota, “Chemical toxicity and reactive oxygen species,” International Journal of Occupational Medicine and Environmental Health, vol. 9, no. 4, pp. 331–340, 1996. View at: Google Scholar
  59. H. P. Misra and I. Fridovich, “The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase,” Journal of Biological Chemistry, vol. 247, no. 10, pp. 3170–3175, 1972. View at: Google Scholar
  60. D. J. Reed, “Toxicity of oxygen,” in Molecular and Cellular Mechanisms of Toxicity, F. De Matteis and L. L. Smith, Eds., pp. 35–68, CRC Press, Boca Raton, Fla, USA, 1995. View at: Google Scholar
  61. B. P. Yu, “Cellular defenses against damage from reactive oxygen species,” Physiological Reviews, vol. 74, no. 1, pp. 139–162, 1994. View at: Google Scholar
  62. I. Stoian, A. Oros, and E. Moldoveanu, “Apoptosis and free radicals,” Biochemical and Molecular Medicine, vol. 59, no. 2, pp. 93–97, 1996. View at: Publisher Site | Google Scholar
  63. M. Younes, “Free radicals and reactive oxygen species, in toxicology, ‘By H. Marguardt, Mechanisms of antioxidant and pro-oxidant effects of lipoic acid in the diabetic and nondiabetic kidney’,” Kidney International, vol. 67, no. 4, pp. 1371–1380, 1999. View at: Google Scholar
  64. D. B. Marks, A. D. Marks, and C. M. Smith, “Oxygen metabolism and toxicityin,” in Basic Medical Biochemistry: A Clinical Approach, pp. 327–340, Williams and Wilkins, Baltimore, Md, USA, 1996. View at: Google Scholar
  65. P. P. Tak and G. S. Firestein, “NF-κB: a key role in inflammatory diseases,” Journal of Clinical Investigation, vol. 107, no. 1, pp. 7–11, 2001. View at: Google Scholar
  66. T. Aw Tak, “Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine,” American Journal of Clinical Nutrition, vol. 70, no. 4, pp. 557–565, 1999. View at: Google Scholar
  67. S. G. Rhee, Y. S. Bae, S. R. Lee, and J. Kwon, “Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation,” Science STKE, vol. 10, no. 53, p. 1, 2000. View at: Google Scholar
  68. X. Liu, C. N. Kim, J. Yang, R. Jemmerson, and X. Wang, “Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c,” Cell, vol. 86, no. 1, pp. 147–157, 1996. View at: Publisher Site | Google Scholar
  69. W. A. Pryor, K. N. Houk, C. S. Foote et al., “Free radical biology and medicine: it's a gas, man!,” American Journal of Physiology, vol. 291, no. 3, pp. R491–R511, 2006. View at: Publisher Site | Google Scholar
  70. R. Olszanecki, A. Gȩbska, V. I. Kozlovski, and R. J. Gryglewski, “Flavonoids and nitric oxide synthase,” Journal of Physiology and Pharmacology, vol. 53, no. 4, pp. 571–584, 2002. View at: Google Scholar
  71. A. Pavanato, M. J. Tuñón, S. Sánchez-Campos, C. A. Marroni, S. Llesuy, and J. González-Gallego, “Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis,” Digestive Diseases and Sciences, vol. 48, no. 4, pp. 824–829, 2003. View at: Publisher Site | Google Scholar
  72. M. Miyamoto, K. Hashimoto, K. Minagawa et al., “Effect of poly-herbal formula on NO production by LPS-stimulated mouse macrophage-like cells,” Anticancer Research A, vol. 22, no. 6, pp. 3293–3301, 2002. View at: Google Scholar
  73. O. Akyol, S. Zoroglu, F. Armutcu, S. Sahin, and A. Gurel, “Nitric oxide as a physiopathological factor in neuropsychiatric disorders,” In Vivo, vol. 18, no. 3, pp. 377–390, 2004. View at: Google Scholar
  74. B. Halliwell and M. Whiteman, “Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean?” British Journal of Pharmacology, vol. 142, no. 2, pp. 231–255, 2004. View at: Publisher Site | Google Scholar
  75. A. B. Knott and E. Bossy-Wetzel, “Nitric oxide in health and disease of the nervous system,” Antioxidants and Redox Signaling, vol. 11, no. 3, pp. 541–553, 2009. View at: Publisher Site | Google Scholar
  76. L. J. Marnett, “Oxyradicals and DNA damage,” Carcinogenesis, vol. 21, no. 3, pp. 361–370, 2000. View at: Google Scholar
  77. T. von Schantz, S. Bensch, M. Grahn, D. Hasselquist, and H. Wittzell, “Good genes, oxidative stress and condition-dependent sexual signals,” Proceedings of the Royal Society B, vol. 266, no. 1414, pp. 1–12, 1999. View at: Publisher Site | Google Scholar
  78. D. Costantini, “Oxidative stress in ecology and evolution: lessons from avian studies,” Ecology Letters, vol. 11, no. 11, pp. 1238–1251, 2008. View at: Publisher Site | Google Scholar
  79. P. Monaghan, N. B. Metcalfe, and R. Torres, “Oxidative stress as a mediator of life history trade-offs: mechanisms, measurements and interpretation,” Ecology Letters, vol. 12, no. 1, pp. 75–92, 2009. View at: Publisher Site | Google Scholar
  80. B. Halliwell and J. M. C. Gutteridge, Free Radicals in Biology and Medicine, Oxford University Press, Oxford, UK, 3rd edition, 2007.
  81. Z. Ďuračková, Ľ. Bergendi, and J. Čársky, Eds., Free Radicals and Antioxidants in Medicine (II), SAP, Bratislava, Slovakia, 1999.
  82. A. H. Klimp, E. G. E. De Vries, G. L. Scherphof, and T. Daemen, “A potential role of macrophage activation in the treatment of cancer,” Critical Reviews in Oncology and Hematology, vol. 44, no. 2, pp. 143–161, 2002. View at: Publisher Site | Google Scholar
  83. Z. Ďuračková, “Some current insights into oxidative stress,” Physiological Research, vol. 59, no. 4, pp. 459–469, 2010. View at: Google Scholar
  84. H. Forman, M. Maiorino, and F. Ursini, “Signaling functions of reactive oxygen species,” Biochemistry, vol. 49, no. 5, pp. 835–842, 2010. View at: Publisher Site | Google Scholar
  85. G. P. Bienert, A. L. B. Møller, K. A. Kristiansen et al., “Specific aquaporins facilitate the diffusion of hydrogen peroxide across membranes,” Journal of Biological Chemistry, vol. 282, no. 2, pp. 1183–1192, 2007. View at: Publisher Site | Google Scholar
  86. N. Makino, K. Sasaki, K. Hashida, and Y. Sakakura, “A metabolic model describing the H2O2 elimination by mammalian cells including H2O2 permeation through cytoplasmic and peroxisomal membranes: comparison with experimental data,” Biochimica et Biophysica Acta, vol. 1673, no. 3, pp. 149–159, 2004. View at: Publisher Site | Google Scholar
  87. R. Nisticò, S. Piccirilli, M. L. Cucchiaroni et al., “Neuroprotective effect of hydrogen peroxide on an in vitro model of brain ischaemia,” British Journal of Pharmacology, vol. 153, no. 5, pp. 1022–1029, 2008. View at: Publisher Site | Google Scholar
  88. T. Finkel, “Oxygen radicals and signaling,” Current Opinion in Cell Biology, vol. 10, no. 2, pp. 248–253, 1998. View at: Publisher Site | Google Scholar
  89. N. K. Tonks, “Redox redux: revisiting PTPs and the control of cell signaling,” Cell, vol. 121, no. 5, pp. 667–670, 2005. View at: Publisher Site | Google Scholar
  90. P. Kovacic and J. D. Jacintho, “Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer,” Current Medicinal Chemistry, vol. 8, no. 7, pp. 773–796, 2001. View at: Google Scholar
  91. L. A. Ridnour, J. S. Isenberg, M. G. Espey, D. D. Thomas, D. D. Roberts, and D. A. Wink, “Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 37, pp. 13147–13152, 2005. View at: Publisher Site | Google Scholar
  92. M. Valko, H. Morris, M. Mazúr, P. Rapta, and R. F. Bilton, “Oxygen free radical generating mechanisms in the colon: do the semiquinones of vitamin K play a role in the aetiology of colon cancer?” Biochimica et Biophysica Acta, vol. 1527, no. 3, pp. 161–166, 2001. View at: Publisher Site | Google Scholar
  93. Z. Ďuračková, “Oxidants, antioxidants and redox stress,” in The Activity of Natural Compounds in Diseases Prevention and Therapy, Z. Ďuračková and S. Knasmüller, Eds., pp. 11–59, SAP, Bratislava, Slovakia, 2007. View at: Google Scholar
  94. M. Dvorakova, B. Höhler, R. Vollerthun, T. Fischbach, and W. Kummer, “Macrophages: a major source of cytochrome b558 in the rat carotid body,” Brain Research, vol. 852, no. 2, pp. 349–354, 2000. View at: Publisher Site | Google Scholar
  95. M. Geiszt, A. Kapus, K. Német, L. Farkas, and E. Ligeti, “Regulation of capacitative Ca2+ influx in human neutrophil granulocytes. Alterations in chronic granulomatous disease,” Journal of Biological Chemistry, vol. 272, no. 42, pp. 26471–26478, 1997. View at: Publisher Site | Google Scholar
  96. G. Cheng, Z. Cao, X. Xu, E. G. V. Meir, and J. D. Lambeth, “Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5,” Gene, vol. 269, no. 1-2, pp. 131–140, 2001. View at: Publisher Site | Google Scholar
  97. G. Dorsam, M. M. Taher, K. C. Valerie, N. B. Kuemmerle, J. C. Chan, and R. C. Franson, “Diphenyleneiodium chloride blocks inflammatory cytokine-induced up-regulation of group IIA phospholipase A(2) in rat mesangial cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 292, no. 1, pp. 271–279, 2000. View at: Google Scholar
  98. J. Racek, V. Treska, V. Krizan, V. Holecek, and Z. Jerabek, “The significance of free radicals in operations of acute ischaemia of the limbs,” Zeitschrift für klinische Chemie und klinische Biochemie, vol. 3, pp. 103–105, 1995. View at: Google Scholar
  99. I. Pechan, K. Danova, I. Olejarova, L. Halcak, V. Rendekova, and J. Fabian, “Oxidative stress and antioxidant defense systems in patients after heart transplantation,” Wiener Klinische Wochenschrift, vol. 115, no. 17-18, pp. 648–651, 2003. View at: Google Scholar
  100. S. W. Ballinger, “Mitochondrial dysfunction in cardiovascular disease,” Free Radical Biology and Medicine, vol. 38, no. 10, pp. 1278–1295, 2005. View at: Publisher Site | Google Scholar
  101. A. Rahman, F. Fazal, J. Greensill, K. Ainley, J. H. Parish, and S. M. Hadi, “Strand scission in DNA induced by dietary flavonoids: role of Cu(I) and oxygen free radicals and biological consequences of scission,” Molecular and Cellular Biochemistry, vol. 111, no. 1-2, pp. 3–9, 1992. View at: Google Scholar
  102. A. Cherubini, C. Ruggiero, M. C. Polidori, and P. Mecocci, “Potential markers of oxidative stress in stroke,” Free Radical Biology and Medicine, vol. 39, no. 7, pp. 841–852, 2005. View at: Publisher Site | Google Scholar
  103. K. P. Singh, A. H. Ahmad, S. K. Hore, V. Singh, M. Lohani, and A. Rahal, “Effect of Emblica officinalis on antioxidative and haematological parameters following mercury induced toxicity,” in Proceedings of the 6th Annual conference of ISVPT, Patna, India, November 2006. View at: Google Scholar
  104. V. Singh, A. Rahal, K. P. Singh, and A. H. Ahmad, “Effect of ethanolic extract of Withania somnifera roots on antioxidant defence in mercury induced toxicity in HepG2 cell line,” Online Journal of Pharmacology and Pharmacokinetics, vol. 5, pp. 65–72, 2009. View at: Google Scholar
  105. V. Singh, A. Rahal, K. P. Singh, and A. H. Ahmad, “Evaluation of prophylactic potential of Withania somnifera roots extract on mercury-induced oxidative damage in various rat tissues,” Journal of Veterinary Pharmacology and Toxicology, vol. 9, no. 1-2, pp. 64–67, 2010. View at: Google Scholar
  106. K. P. Singh, A. H. Ahmad, V. Singh, K. Pant, and A. Rahal, “Effect of Emblica officinalis fruit in combating mercury-induced hepatic oxidative stress in rats,” Indian Journal of Animal Sciences, vol. 81, no. 3, pp. 260–262, 2011. View at: Google Scholar
  107. M. B. Hampton, A. J. Kettle, and C. C. Winterbourn, “Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing,” Blood, vol. 92, no. 9, pp. 3007–3017, 1998. View at: Google Scholar
  108. B. M. Babior, “NADPH oxidase: an update,” Blood, vol. 93, no. 5, pp. 1464–1476, 1999. View at: Google Scholar
  109. C. A. Rice-Evans and V. Gopinathan, “Oxygen toxicity, free radicals and antioxidants in human disease: biochemical implications in atherosclerosis and the problems of premature neonates,” Essays in Biochemistry, vol. 29, pp. 39–63, 1995. View at: Google Scholar
  110. N. Valero, J. Mosquera, G. Añez, A. Levy, R. Marcucci, and D. M. Melchor, “Differential oxidative stress Induced by dengue virus in monocytes from human neonates, adult and elderly individuals,” PLoS ONE, vol. 8, no. 9, Article ID e73221, 2013. View at: Publisher Site | Google Scholar
  111. A. Csillag, I. Boldogh, K. Pazmandi et al., “Pollen-induced oxidative stress influences both innate and adaptive immune responses via altering dendritic cell functions,” Journal of Immunology, vol. 184, no. 5, pp. 2377–2385, 2010. View at: Publisher Site | Google Scholar
  112. W. E. Stehbens, “Oxidative stress in viral hepatitis and AIDS,” Experimental and Molecular Pathology, vol. 77, no. 2, pp. 121–132, 2004. View at: Publisher Site | Google Scholar
  113. P. D. Hodgson, P. Aich, J. Stookey et al., “Stress significantly increases mortality following a secondary bacterial respiratory infection,” Veterinary Research, vol. 43, p. 21, 2012. View at: Publisher Site | Google Scholar
  114. E. E. Gordon, “Altered oligosaccharides as the initiating autoantigen in rheumatoid arthritis,” Medical Hypotheses, vol. 10, no. 4, pp. 347–352, 1983. View at: Google Scholar
  115. M. Abu-Shakra and Y. Shoenfeld, “Parasitic infection and autoimmunity,” Autoimmunity, vol. 9, no. 4, pp. 337–344, 1991. View at: Google Scholar
  116. I. Dalle-Donne, A. Scaloni, D. Giustarini et al., “Proteins as biomarkers of oxidattiv/e/nitrosative stress in diseases: the contribution of redox proteomics,” Mass Spectrometry Reviews, vol. 24, no. 1, pp. 55–99, 2005. View at: Publisher Site | Google Scholar
  117. M. E. Allison and D. T. Fearon, “Enhanced immunogenicity of aldehyde bearing antigens: a possible link between innate and adaptive immunity,” European Journal of Immunology, vol. 10, pp. 2881–2887, 2000. View at: Google Scholar
  118. R. H. Scofield, B. T. Kurien, S. Ganick et al., “Modification of lupus-associated 60-kDa Ro protein with the lipid oxidation product 4-hydroxy-2-nonenal increases antigenicity and facilitates epitope spreading,” Free Radical Biology and Medicine, vol. 38, no. 6, pp. 719–728, 2005. View at: Publisher Site | Google Scholar
  119. S. M. Trigwell, P. M. Radford, S. R. Page et al., “Islet glutamic acid decarboxylase modified by reactive oxygen species is recognized by antibodies from patients with type 1 diabetes mellitus,” Clinical and Experimental Immunology, vol. 126, no. 2, pp. 242–249, 2001. View at: Publisher Site | Google Scholar
  120. L. Casciola-Rosen, F. Wigley, and A. Rosen, “Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis,” Journal of Experimental Medicine, vol. 185, no. 1, pp. 71–79, 1997. View at: Publisher Site | Google Scholar
  121. B. Buttari, E. Profumo, V. Mattei et al., “Oxidized β2-glycoprotein I induces human dendritic cell maturation and promotes a T helper type 1 response,” Blood, vol. 106, no. 12, pp. 3880–3887, 2005. View at: Publisher Site | Google Scholar
  122. S. E. Gandy, M. G. Buse, and R. K. Crouch, “Protective role of superoxide dismutase against diabetogenic drugs,” Journal of Clinical Investigation, vol. 70, no. 3, pp. 650–658, 1982. View at: Google Scholar
  123. I. C. Gerling, “Oxidative Stress, altered-Self and autoimmunity,” The Open Autoimmunity Journal, vol. 1, pp. 33–36, 2009. View at: Publisher Site | Google Scholar
  124. L. Stojanovich, “Stress and autoimmunity,” Autoimmunity Reviews, vol. 9, no. 5, pp. A271–A276, 2010. View at: Publisher Site | Google Scholar
  125. C. Nathan and M. U. Shiloh, “Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens,” Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 16, pp. 8841–8848, 2000. View at: Publisher Site | Google Scholar
  126. G. Sorci and B. Faivre, “Inflammation and oxidative stress in vertebrate host-parasite systems,” Philosophical Transactions of the Royal Society B, vol. 364, no. 1513, pp. 71–83, 2009. View at: Publisher Site | Google Scholar
  127. M. A. Puertollano, E. Puertollano, G. Á. de Cienfuegos, and M. A. de Pablo, “Dietary antioxidants: immunity and host defense,” Current Topics in Medicinal Chemistry, vol. 11, no. 14, pp. 1752–1766, 2011. View at: Publisher Site | Google Scholar
  128. S. S. Leonard, G. K. Harris, and X. Shi, “Metal-induced oxidative stress and signal transduction,” Free Radical Biology and Medicine, vol. 37, no. 12, pp. 1921–1942, 2004. View at: Publisher Site | Google Scholar
  129. T. B. Kryston, A. B. Georgiev, P. Pissis, and A. G. Georgakilas, “Role of oxidative stress and DNA damage in human carcinogenesis,” Mutation Research, vol. 711, no. 1-2, pp. 193–201, 2011. View at: Publisher Site | Google Scholar
  130. M. Khatami, “Unresolved inflammation: “Immune tsunami” or erosion of integrity in immune-privileged and immune-responsive tissues and acute and chronic inflammatory diseases or cancer,” Expert Opinion on Biological Therapy, vol. 11, no. 11, pp. 1419–1432, 2011. View at: Publisher Site | Google Scholar
  131. K. O'Brien, D. C. Fitzgerald, K. Naiken, K. R. Alugupalli, A. M. Rostami, and B. Gran, “Role of the innate immune system in autoimmune inflammatory demyelination,” Current Medicinal Chemistry, vol. 15, no. 11, pp. 1105–1115, 2008. View at: Publisher Site | Google Scholar
  132. R. Schneider, A. N. Mohebiany, I. Ifergan et al., “B cell-derived IL-15 enhances CD8 T cell cytotoxicity and is increased in multiple sclerosis patients,” Journal of Immunology, vol. 187, no. 8, pp. 4119–4128, 2011. View at: Publisher Site | Google Scholar
  133. A. J. Muller, M. D. Sharma, P. R. Chandler et al., “Chronic inflammation that facilitates tumor progression creates local immune suppression by inducing indoleamine 2,3 dioxygenase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 44, pp. 17073–17078, 2008. View at: Publisher Site | Google Scholar
  134. K. Zhang, “Integration of ER stress, oxidative stress and the inflammatory response in health and disease,” International Journal of Clinical and Experimental Medicine, vol. 3, no. 1, pp. 33–40, 2010. View at: Google Scholar
  135. A. R. Davalos, J. Coppe, J. Campisi, and P. Desprez, “Senescent cells as a source of inflammatory factors for tumor progression,” Cancer and Metastasis Reviews, vol. 29, no. 2, pp. 273–283, 2010. View at: Publisher Site | Google Scholar
  136. F. Innocenti, N. J. Cox, and M. E. Dolan, “The use of genomic information to optimize cancer chemotherapy,” Seminars in Oncology, vol. 38, no. 2, pp. 186–195, 2011. View at: Publisher Site | Google Scholar
  137. B. Vire, A. David, and A. Wiestner, “TOSO, the Fcμ receptor, is highly expressed on chronic lymphocytic leukemia B cells, internalizes upon IgM binding, shuttles to the lysosome, and is downregulated in response to TLR activation,” Journal of Immunology, vol. 187, no. 8, pp. 4040–4050, 2011. View at: Publisher Site | Google Scholar
  138. G. Pellegriti, F. Frasca, C. Regalbuto, S. Squatrito, and R. Vigneri, “Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors,” Journal of Cancer Epidemiology, vol. 2013, Article ID 965212, 10 pages, 2013. View at: Publisher Site | Google Scholar
  139. A. D. Romano, G. Serviddio, A. De Matthaeis, F. Bellanti, and G. Vendemiale, “Oxidative stress and aging,” Journal of Nephrology, vol. 23, supplement 15, pp. S29–S36, 2010. View at: Google Scholar
  140. D. Harman, “Aging: overview,” Annals of the New York Academy of Sciences, vol. 928, pp. 1–21, 2001. View at: Google Scholar
  141. J. Bejma and L. L. Ji, “Aging and acute exercise enhance free radical generation in rat skeletal muscle,” Journal of Applied Physiology, vol. 87, no. 1, pp. 465–470, 1999. View at: Google Scholar
  142. B. Bejma, R. Ramires, and J. Ji, “Free radical generation and oxidative stress with ageing and exercise: differential effects in the myocardium and liver,” Acta Physiologica Scandinavica, vol. 169, no. 4, pp. 343–351, 2000. View at: Publisher Site | Google Scholar
  143. A. S. Driver, P. R. S. Kodavanti, and W. R. Mundy, “Age-related changes in reactive oxygen species production in rat brain homogenates,” Neurotoxicology and Teratology, vol. 22, no. 2, pp. 175–181, 2000. View at: Publisher Site | Google Scholar
  144. F. Gomi, H. Utsumi, A. Hamada, and M. Matsuo, “Aging retards spin clearance from mouse brain and food restriction prevents its age-dependent retardation,” Life Sciences, vol. 52, no. 25, pp. 2027–2033, 1993. View at: Publisher Site | Google Scholar
  145. H. J. Zhang, L. Xu, V. J. Drake, L. Xie, L. W. Oberley, and K. C. Kregel, “Heat-induced liver injury in old rats is associated with exaggerated oxidative stress and altered transcription factor activation,” FASEB Journal, vol. 17, no. 15, pp. 2293–2295, 2003. View at: Publisher Site | Google Scholar
  146. K. C. Kregel and H. J. Zhang, “An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations,” American Journal of Physiology, vol. 292, no. 1, pp. R18–R36, 2007. View at: Publisher Site | Google Scholar
  147. T. M. Hagen, “Oxidative stress, redox imbalance, and the aging process,” Antioxidants and Redox Signaling, vol. 5, no. 5, pp. 503–506, 2003. View at: Google Scholar
  148. N. Babbar and E. W. Gerner, “Targeting polyamines and inflammation for cancer prevention,” Recent Results in Cancer Research, vol. 188, pp. 49–64, 2011. View at: Publisher Site | Google Scholar
  149. D. S. Shames, J. D. Minna, and A. F. Gazdar, “DNA methylation in health, disease, and cancer,” Current Molecular Medicine, vol. 7, no. 1, pp. 85–102, 2007. View at: Publisher Site | Google Scholar
  150. G. Aubert and P. M. Lansdorp, “Telomeres and aging,” Physiological Reviews, vol. 88, no. 2, pp. 557–579, 2008. View at: Publisher Site | Google Scholar
  151. J. M. Zingg, A. Azzi, and M. Meydani, “Genetic polymorphisms as determinants for disease-preventive effects of vitamin E,” Nutrition Reviews, vol. 66, no. 7, pp. 406–414, 2008. View at: Publisher Site | Google Scholar
  152. M. Khatami, “Inflammation, aging, and cancer: tumoricidal versus tumorigenesis of immunity,” Cell Biochemistry and Biophysics, vol. 55, no. 2, pp. 55–79, 2009. View at: Publisher Site | Google Scholar
  153. N. C. Laddha, M. Dwivedi, M. S. Mansuri et al., “Vitiligo: interplay between oxidative stress and immune system,” Experimental Dermatology, vol. 22, no. 4, pp. 245–250, 2013. View at: Publisher Site | Google Scholar
  154. E. Erbay, V. R. Babaev, J. R. Mayers et al., “Reducing endoplasmic reticulum stress through a macrophage lipid chaperone alleviates atherosclerosis,” Natural Medicine, vol. 15, pp. 1383–1391, 2009. View at: Publisher Site | Google Scholar
  155. E. Albano, “Oxidative mechanisms in the pathogenesis of alcoholic liver disease,” Molecular Aspects of Medicine, vol. 29, no. 1-2, pp. 9–16, 2008. View at: Publisher Site | Google Scholar
  156. B. Halliwell, “Oxidative stress and neurodegeneration: where are we now?” Journal of Neurochemistry, vol. 97, no. 6, pp. 1634–1658, 2006. View at: Publisher Site | Google Scholar
  157. L. A. Brown, F. L. Harris, and D. P. Jones, “Ascorbate deficiency and oxidative stress in the alveolar type II cell,” American Journal of Physiology, vol. 273, no. 4, pp. L782–L788, 1997. View at: Google Scholar
  158. W. R. Markesbery, “Oxidative stress hypothesis in Alzheimer's disease,” Free Radical Biology and Medicine, vol. 23, no. 1, pp. 134–147, 1997. View at: Publisher Site | Google Scholar
  159. D. A. Butterfield and J. Kanski, “Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins,” Mechanisms of Ageing and Development, vol. 122, no. 9, pp. 945–962, 2001. View at: Publisher Site | Google Scholar
  160. D. A. Butterfield and C. M. Lauderback, “Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress,” Free Radical Biology and Medicine, vol. 32, no. 11, pp. 1050–1060, 2002. View at: Publisher Site | Google Scholar
  161. B. I. Giasson, H. Ischiropoulos, V. M.-Y. Lee, and J. Q. Trojanowski, “The relationship between oxidative/nitrative stress and pathological inclusions in Alzheimer's and Parkinson's diseases,” Free Radical Biology and Medicine, vol. 32, no. 12, pp. 1264–1275, 2002. View at: Publisher Site | Google Scholar
  162. X. Zhu, M. A. Smith, G. Perry, and G. Aliev, “Mitochondrial failures in Alzheimer's disease,” American Journal of Alzheimer's Disease and other Dementias, vol. 19, no. 6, pp. 345–352, 2004. View at: Google Scholar
  163. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini, and A. Milzani, “Biomarkers of oxidative damage in human disease,” Clinical Chemistry, vol. 52, no. 4, pp. 601–623, 2006. View at: Publisher Site | Google Scholar
  164. B. T. Kurien, K. Hensley, M. Bachmann, and R. H. Scofield, “Oxidatively modified autoantigens in autoimmune diseases,” Free Radical Biology and Medicine, vol. 41, no. 4, pp. 549–556, 2006. View at: Publisher Site | Google Scholar
  165. B. Halliwell, “Are polyphenols antioxidants or pro-oxidants? What do we learn from cell culture and in vivo studies?” Archives of Biochemistry and Biophysics, vol. 476, no. 2, pp. 107–112, 2008. View at: Publisher Site | Google Scholar
  166. S. C. Sahu and G. C. Gray, “Interactions of flavonoids, trace metals, and oxygen: nuclear DNA damage and lipid peroxidation induced by myricetin,” Cancer Letters, vol. 70, no. 1-2, pp. 73–79, 1993. View at: Google Scholar
  167. S. C. Sahu and G. C. Gray, “Kaempferol-induced nuclear DNA damage and lipid peroxidation,” Cancer Letters, vol. 85, no. 2, pp. 159–164, 1994. View at: Publisher Site | Google Scholar
  168. M. S. Ahmad, F. Fazal, A. Rahman, S. M. Hadi, and J. H. Parish, “Activities of flavonoids for the cleavage of DNA in the presence of Cu(II): correlation with generation of active oxygen species,” Carcinogenesis, vol. 13, no. 4, pp. 605–608, 1992. View at: Google Scholar
  169. C. A. Rice-Evans, N. J. Miller, P. G. Bolwell, P. M. Bramley, and J. B. Pridham, “The relative antioxidant activities of plant-derived polyphenolic flavonoids,” Free Radical Research, vol. 22, no. 4, pp. 375–383, 1995. View at: Google Scholar
  170. G. Guohua, S. Emin, and L. Ronald, “Antioxidant and prooxidant behavior of flavonoids: structure-activity relationships,” Free Radical Biology and Medicine, vol. 22, no. 5, pp. 749–760, 1997. View at: Publisher Site | Google Scholar
  171. K. Ioku, T. Tsushida, Y. Takei, N. Nakatani, and J. Terao, “Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers,” Biochimica et Biophysica Acta, vol. 1234, no. 1, pp. 99–104, 1995. View at: Publisher Site | Google Scholar
  172. G. O. Igile, W. Oleszek, M. Jurzysta, S. Burda, M. Fafunso, and A. A. Fasanmade, “Flavonoids from Vernonia amygdalina and their antioxidant activities,” Journal of Agricultural and Food Chemistry, vol. 42, no. 11, pp. 2445–2448, 1994. View at: Google Scholar
  173. G. Weiss, G. Werner-Felmayer, E. R. Werner, K. Grünewald, H. Wachter, and M. W. Hentze, “Iron regulates nitric oxide synthase activity by controlling nuclear transcription,” Journal of Experimental Medicine, vol. 180, no. 3, pp. 969–976, 1994. View at: Publisher Site | Google Scholar
  174. M. J. Laughton, P. J. Evans, M. A. Moroney, J. R. S. Hoult, and B. Halliwell, “Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability,” Biochemical Pharmacology, vol. 42, no. 9, pp. 1673–1681, 1991. View at: Publisher Site | Google Scholar
  175. A. P. Lin, W. J. Tsai, C. Y. Fan, and M. J. Lee, “Vandellia cordifolia regulated cell proliferation and cytokines production in human mononuclear cells,” American Journal of Chinese Medicine, vol. 28, no. 3-4, pp. 313–323, 2000. View at: Google Scholar
  176. J. Lee, E. R. Hahm, and S. V. Singh, “Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells,” Carcinogenesis, vol. 31, no. 11, pp. 1991–1998, 2010. View at: Publisher Site | Google Scholar
  177. C. A. Lastra and I. Villegas, “Resveratrol as an antioxidant and pro-oxidant agent: mechanisms and clinical implications,” Biochemical Society Transactions, vol. 35, no. 5, pp. 1156–1160, 2007. View at: Publisher Site | Google Scholar
  178. M. Y. Seo and S. M. Lee, “Protective effect of low dose of ascorbic acid on hepatobiliary function in hepatic ischemia/reperfusion in rats,” Journal of Hepatology, vol. 36, no. 1, pp. 72–77, 2002. View at: Publisher Site | Google Scholar
  179. G. R. Buettner and B. A. Jurkiewicz, “Catalytic metals, ascorbate and free radicals: combinations to avoid,” Radiation Research, vol. 145, no. 5, pp. 532–541, 1996. View at: Publisher Site | Google Scholar
  180. G. R. Buettner, “The pecking order of free radicals and antioxidants: lipid peroxidation, α-tocopherol, and ascorbate,” Archives of Biochemistry and Biophysics, vol. 300, no. 2, pp. 535–543, 1993. View at: Publisher Site | Google Scholar
  181. F.-F. Zhang, Y.-F. Zheng, H.-J. Zhu, X.-Y. Shen, and X.-Q. Zhu, “Effects of kaempferol and quercetin on cytochrome 450 activities in primarily cultured rat hepatocytes,” Zhejiang Da Xue Xue Bao Yi Xue Ban, vol. 35, no. 1, pp. 18–22, 2006. View at: Google Scholar
  182. H.-T. Yao, M.-N. Luo, L.-B. Hung et al., “Effects of chitosan oligosaccharides on drug-metabolizing enzymes in rat liver and kidneys,” Food and Chemical Toxicology, vol. 50, no. 5, pp. 1171–1177, 2012. View at: Publisher Site | Google Scholar
  183. V. Hebbar, G. Shen, R. Hu et al., “Toxicogenomics of resveratrol in rat liver,” Life Sciences, vol. 76, no. 20, pp. 2299–2314, 2005. View at: Publisher Site | Google Scholar
  184. A. J. Young and G. M. Lowe, “Antioxidant and prooxidant properties of carotenoids,” Archives of Biochemistry and Biophysics, vol. 385, no. 1, pp. 20–27, 2001. View at: Publisher Site | Google Scholar
  185. A. Kontush, B. Finckh, B. Karten, A. Kohlschütter, and U. Beisiegel, “Antioxidant and prooxidant activity of α-tocopherol in human plasma and low density lipoprotein,” Journal of Lipid Research, vol. 37, no. 7, pp. 1436–1448, 1996. View at: Google Scholar
  186. B. C. Scott, O. I. Aruoma, P. J. Evansi et al., “Lipoic and dihydrolipoic acids as antioxidants. A critical evaluation,” Free Radical Research, vol. 20, no. 2, pp. 119–133, 1994. View at: Google Scholar
  187. H. Moini, L. Packer, and N. L. Saris, “Antioxidant and prooxidant activities of α-lipoic acid and dihydrolipoic acid,” Toxicology and Applied Pharmacology, vol. 182, no. 1, pp. 84–90, 2002. View at: Publisher Site | Google Scholar
  188. M. Rasool and P. Varalakshmi, “Immunomodulatory role of Withania somnifera root powder on experimental induced inflammation: an in vivo and in vitro study,” Vascular Pharmacology, vol. 44, no. 6, pp. 406–410, 2006. View at: Publisher Site | Google Scholar
  189. M. Ahmad, S. Saleem, A. S. Ahmad et al., “Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats,” Human and Experimental Toxicology, vol. 24, no. 3, pp. 137–147, 2005. View at: Publisher Site | Google Scholar
  190. M. Owais, K. S. Sharad, A. Shehbaz, and M. Saleemuddin, “Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis,” Phytomedicine, vol. 12, no. 3, pp. 229–235, 2005. View at: Publisher Site | Google Scholar
  191. S. K. Gupta, I. Mohanty, K. K. Talwar et al., “Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment,” Molecular and Cellular Biochemistry, vol. 260, no. 1, pp. 39–47, 2004. View at: Publisher Site | Google Scholar
  192. S. Srinivasan, R. S. Ranga, R. Burikhanov, S. Han, and D. Chendil, “Par-4-dependent apoptosis by the dietary compound withaferin A in prostate cancer cells,” Cancer Research, vol. 67, no. 1, pp. 246–253, 2007. View at: Publisher Site | Google Scholar
  193. F. Malik, A. Kumar, S. Bhushan et al., “Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary compound withaferin A with concomitant protection by N-acetyl cysteine,” Apoptosis, vol. 12, no. 11, pp. 2115–2133, 2007. View at: Publisher Site | Google Scholar
  194. S. D. Stan, E. Hahm, R. Warin, and S. V. Singh, “Withaferin A causes FOXO3a- and Bim-dependent apoptosis and inhibits growth of human breast cancer cells in vivo,” Cancer Research, vol. 68, no. 18, pp. 7661–7669, 2008. View at: Publisher Site | Google Scholar
  195. S. D. Stan, Y. Zeng, and S. V. Singh, “Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells,” Nutrition and Cancer, vol. 60, no. 1, pp. 51–60, 2008. View at: Publisher Site | Google Scholar
  196. J. H. Oh, T. Lee, S. H. Kim et al., “Induction of apoptosis by withaferin A in human leukemia U937 cells through down-regulation of Akt phosphorylation,” Apoptosis, vol. 13, no. 12, pp. 1494–1504, 2008. View at: Publisher Site | Google Scholar
  197. C. Mandal, A. Dutta, A. Mallick et al., “Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade,” Apoptosis, vol. 13, no. 12, pp. 1450–1464, 2008. View at: Publisher Site | Google Scholar
  198. Y. Yu, A. Hamza, T. Zhang et al., “Withaferin A targets heat shock protein 90 in pancreatic cancer cells,” Biochemical Pharmacology, vol. 79, no. 4, pp. 542–551, 2010. View at: Publisher Site | Google Scholar
  199. E. R. Hahm, M. B. Moura, E. E. Kelley, B. van Houten, S. Shiva, and S. V. Singh, “Withaferin a-induced apoptosis in human breast cancer cells is mediated by reactive oxygen species,” PLoS ONE, vol. 6, no. 8, Article ID e23354, 2011. View at: Publisher Site | Google Scholar
  200. V. Schulz, R. Hänsel, and V. Tyler, Rational Phytotherapy: A Physician’s Guide to Herbal Medicine, Springer, Berlin, Germany, 1998.
  201. A. S. Attele, J. A. Wu, and C. Yuan, “Ginseng pharmacology: multiple constituents and multiple actions,” Biochemical Pharmacology, vol. 58, no. 11, pp. 1685–1693, 1999. View at: Publisher Site | Google Scholar
  202. K. C. Huang, Pharmacology of Chinese Herbs, CRC Press, Boca Raton, Fla, USA, 1999.
  203. M. Blumenthal, A. Goldberg, and J. Brinckmann, “Herbal medicine: expanded commission E monographs,” Integrative Medicine Communications, vol. 133, no. 6, p. 487, 2000. View at: Publisher Site | Google Scholar
  204. J. Bruneton, Pharmacognosy, Phytochemistry, Medicinal Plants, Lavisior, Paris, France, 1995.
  205. P. M. Dewick, Medicinal Natural Products, John Wiley & Sons, West Sussex, UK, 1997.
  206. S. Beatty, H. Koh, M. Phil, D. Henson, and M. Boulton, “The role of oxidative stress in the pathogenesis of age-related macular degeneration,” Survey of Ophthalmology, vol. 45, no. 2, pp. 115–134, 2000. View at: Publisher Site | Google Scholar
  207. A. C. Maritim, R. A. Sanders, and J. B. Watkins III, “Diabetes, oxidative stress, and antioxidants: a review,” Journal of Biochemical and Molecular Toxicology, vol. 17, no. 1, pp. 24–38, 2003. View at: Publisher Site | Google Scholar
  208. S. Fulle, T. Pietrangelo, R. Mancinelli, R. Saggini, and G. Fanò, “Specific correlations between muscle oxidative stress and chronic fatigue syndrome: a working hypothesis,” Journal of Muscle Research and Cell Motility, vol. 28, no. 6, pp. 355–362, 2007. View at: Publisher Site | Google Scholar
  209. U. Singh and I. Jialal, “Oxidative stress and atherosclerosis,” Pathophysiology, vol. 13, no. 3, pp. 129–142, 2006. View at: Publisher Site | Google Scholar
  210. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, “Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options,” Current Neuropharmacology, vol. 7, no. 1, pp. 65–74, 2009. View at: Publisher Site | Google Scholar
  211. Y. S. Cho and H. Moon, “The role of oxidative stress in the pathogenesis of asthma,” Allergy, Asthma and Immunology Research, vol. 2, no. 3, pp. 183–187, 2010. View at: Publisher Site | Google Scholar
  212. A. C. Blackburn, M. Coggan, A. J. Shield et al., “Glutathione transferase kappa deficiency causes glomerular nephropathy without overt oxidative stress,” Laboratory Investigation, vol. 91, no. 11, pp. 1572–1583, 2011. View at: Publisher Site | Google Scholar
  213. C. Ziskoven, M. Jäger, C. Zilkens, W. Bloch, K. Brixius, and R. Krauspe, “Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation?” Orthopedic Reviews, vol. 2, no. 2, p. e23, 2010. View at: Google Scholar
  214. C. S. Sander, F. Hamm, P. Elsner, and J. J. Thiele, “Oxidative stress in malignant melanoma and non-melanoma skin cancer,” British Journal of Dermatology, vol. 148, no. 5, pp. 913–922, 2003. View at: Publisher Site | Google Scholar
  215. C. D. Filippo, S. Cuzzocrea, F. Rossi, R. Marfella, and M. D'Amico, “Oxidative stress as the leading cause of acute myocardial infarction in diabetics,” Cardiovascular Drug Reviews, vol. 24, no. 2, pp. 77–87, 2006. View at: Publisher Site | Google Scholar

Copyright © 2014 Anu Rahal et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Related articles

No related content is available yet for this article.
 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

No related content is available yet for this article.

Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.